sulfur oxoanion - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	sulfur oxoanion	go back to main search page
Accession:	CHEBI:33482	browse the term
Synonyms:	related_synonym:	oxoanions of sulfur; sulfur oxoanions

show annotations for term's descendants Sort by:
Rat (762 ) Mouse (769 ) Human (828 ) Chinchilla (0 ) Bonobo (0 ) Dog (1 ) Squirrel (0 ) Pig (3 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (762)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

affects binding

ISO

chromotrope 2R binds to ALB protein

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

benzenesulfonates

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 10 member 1

multiple interactions

ISO

Benzenesulfonates analog inhibits the reaction [SLC10A1 protein results in increased transport of Taurocholic Acid]

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

brilliant green

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

caspase 3

multiple interactions

ISO

brilliant green results in increased cleavage of and results in increased activity of CASP3 protein

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 7

multiple interactions

ISO

brilliant green results in increased cleavage of and results in increased activity of CASP7 protein

NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512

G

cyclin D1

decreases expression

ISO

brilliant green results in decreased expression of CCND1 protein

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

inhibitor of nuclear factor kappa B kinase subunit epsilon

decreases expression

ISO

brilliant green results in decreased expression of IKBKE protein

NCBI chr13:45,264,404...45,290,737
Ensembl chr13:45,264,412...45,289,396

G

lon peptidase 1, mitochondrial

increases expression

ISO

brilliant green results in increased expression of LONP1 mRNA

NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,534,584...1,547,427

G

solute carrier family 22 member 2

multiple interactions

ISO

brilliant green inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]

NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019

G

thioredoxin 1

increases oxidation

ISO

brilliant green results in increased oxidation of TXN protein

NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307

G

thioredoxin 2

decreases expression
affects response to substance
multiple interactions

ISO

brilliant green results in decreased expression of TXN2 protein
TXN2 protein affects the susceptibility to brilliant green
brilliant green results in increased oxidation of and results in increased degradation of TXN2 protein

NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

amyloid beta precursor protein

multiple interactions
affects binding

EXP
ISO

Congo Red inhibits the reaction [APP protein binds to APP protein]
Congo Red binds to APP protein

PMID:17323972 PMID:17406451

NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971

G

prion protein

decreases expression

ISO

Congo Red results in decreased expression of PRNP protein alternative form

NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetylcholinesterase

increases activity

ISO

Dithionite results in increased activity of ACHE protein

NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410

G

acid phosphatase 5, tartrate resistant

decreases activity
multiple interactions

EXP

Dithionite results in decreased activity of ACP5 protein
ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein]

NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929

G

AKT serine/threonine kinase 1

multiple interactions

EXP

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

BCL2 associated X, apoptosis regulator

multiple interactions
increases expression

EXP
ISO

[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein]
dihydroactinidiolide inhibits the reaction [Dithionite results in increased expression of BAX protein]

PMID:21803128 PMID:33617922

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

multiple interactions
decreases expression

EXP
ISO

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
dihydroactinidiolide inhibits the reaction [Dithionite results in decreased expression of BCL2 protein]

PMID:21803128 PMID:33617922

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

complement C5

multiple interactions

ISO

Dithionite inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of C5 protein]; Dithionite inhibits the reaction [Asbestos, Serpentine results in increased cleavage of C5 protein]

NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468

G

caspase 3

multiple interactions
increases expression
increases activity

EXP
ISO

[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]
Dithionite results in increased expression of CASP3 protein
Dithionite results in increased activity of CASP3 protein

PMID:21803128 PMID:33617922 PMID:34078833

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

dynamin 1-like

multiple interactions

ISO

[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein; [Dithionite results in increased reduction of Paraquat] which results in increased expression of DNM1L protein

NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420

G

glutamate ionotropic receptor AMPA type subunit 2

multiple interactions

EXP

[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein]

NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616

G

heme oxygenase 1

multiple interactions

ISO

[dihydroactinidiolide co-treated with Dithionite] results in increased expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

microRNA 205

multiple interactions

EXP

[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA]

NCBI chr13:107,564,535...107,564,642

G

NFE2 like bZIP transcription factor 2

multiple interactions

ISO

[dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

PTEN induced kinase 1

multiple interactions

EXP

[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]

NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950

G

solute carrier family 6 member 3

multiple interactions

ISO

[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein

NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

allograft inflammatory factor 1

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of AIF1 protein]

NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339

G

brain-derived neurotrophic factor

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in decreased expression of BDNF protein]

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

Fc gamma receptor 2A

decreases phosphorylation
decreases expression

ISO

Fast Green FCF results in decreased phosphorylation of FCGR3 protein
Fast Green FCF results in decreased expression of FCGR3 mRNA

NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394

G

glial fibrillary acidic protein

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]

NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685

G

interleukin 1 beta

decreases expression
multiple interactions

ISO

Fast Green FCF results in decreased expression of IL1B mRNA; Fast Green FCF results in decreased expression of IL1B protein
Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]

PMID:31139084 PMID:37301120

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

decreases expression
multiple interactions

ISO

Fast Green FCF results in decreased expression of IL6 mRNA; Fast Green FCF results in decreased expression of IL6 protein
Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]

PMID:31139084 PMID:37301120

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

iodotyrosine deiodinase

multiple interactions

ISO

Fast Green FCF inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386

G

mannose receptor, C type 1

decreases expression

ISO

Fast Green FCF results in decreased expression of MRC1 mRNA

NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410

G

MYD88, innate immune signal transduction adaptor

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]; Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]

NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230

G

purinergic receptor P2X 4

decreases expression

ISO

Fast Green FCF results in decreased expression of P2RX4 mRNA; Fast Green FCF results in decreased expression of P2RX4 protein

NCBI chr12:39,505,438...39,523,349
Ensembl chr12:39,505,438...39,523,094

G

Pannexin 1

decreases activity

ISO

Fast Green FCF results in decreased activity of PANX1 protein

NCBI chr 8:20,128,783...20,171,200
Ensembl chr 8:20,132,165...20,171,200

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

toll-like receptor 4

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]

NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007

G

tumor necrosis factor

multiple interactions

ISO

Fast Green FCF inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

glucoerucin(1-)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome P450, family 1, subfamily a, polypeptide 1

increases expression

EXP

glucoerucin results in increased expression of CYP1A1 protein

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression

EXP

glucoerucin results in increased expression of CYP1A2 protein

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 1, subfamily b, polypeptide 1

increases expression

EXP

glucoerucin results in increased expression of CYP1B1 protein

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142

G

epoxide hydrolase 1

increases expression

EXP

glucoerucin results in increased expression of EPHX1 protein

NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981

G

NAD(P)H quinone dehydrogenase 1

increases activity

EXP

glucoerucin results in increased activity of NQO1 protein

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aryl hydrocarbon receptor

multiple interactions
affects binding

ISO

Indigo Carmine binds to and results in increased activity of AHR protein
Indigo Carmine binds to AHR protein

PMID:11425848 PMID:15001395

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

albumin

affects binding

ISO

Indigo Carmine binds to ALB protein

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

cholinergic receptor nicotinic alpha 4 subunit

multiple interactions

EXP

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein

NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105

G

cholinergic receptor nicotinic beta 2 subunit

multiple interactions

EXP

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in increased expression of CHRNB2 protein

NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326

G

cytochrome P450, family 1, subfamily a, polypeptide 1

increases activity
increases expression
multiple interactions

ISO
EXP

Indigo Carmine results in increased activity of CYP1A1 protein
Indigo Carmine results in increased expression of CYP1A1 mRNA
Indigo Carmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]

PMID:15001395 PMID:15882963 PMID:18493746

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

glutamate ionotropic receptor NMDA type subunit 2A

multiple interactions

EXP

[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in increased expression of GRIN2A protein

PMID:23429044 PMID:31679476

NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378

G

glutamate ionotropic receptor NMDA type subunit 2B

multiple interactions

EXP

[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in decreased expression of GRIN2B protein

NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570

indocyanine green

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 11

multiple interactions
decreases activity

ISO

Indocyanine Green inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Indocyanine Green results in decreased activity of ABCB11 protein

NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581

G

ATP binding cassette subfamily B member 4

affects export

ISO

ABCB4 protein affects the export of Indocyanine Green

NCBI chr 4:26,106,895...26,164,440

G

BCL2 associated X, apoptosis regulator

increases expression

ISO

Indocyanine Green results in increased expression of BAX mRNA; Indocyanine Green results in increased expression of BAX protein

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

caspase 9

increases expression

ISO

Indocyanine Green results in increased expression of CASP9 mRNA; Indocyanine Green results in increased expression of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

solute carrier family 10 member 1

increases uptake
multiple interactions

ISO

SLC10A1 protein results in increased uptake of Indocyanine Green
Nifedipine promotes the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green]; Taurocholic Acid inhibits the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green]

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 10 member 2

increases uptake

ISO

SLC10A2 protein results in increased uptake of Indocyanine Green

NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025

G

solute carrier family 16 member 2

multiple interactions

ISO

Indocyanine Green inhibits the reaction [SLC16A2 protein results in increased uptake of Triiodothyronine]

NCBI chr X:72,791,096...72,914,299
Ensembl chr X:72,781,876...72,914,498

G

solute carrier family 22 member 7

multiple interactions

ISO

Indocyanine Green inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]

NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681

G

solute carrier family 22 member 8

multiple interactions

EXP

Indocyanine Green inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588

lucifer yellow dye

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily G member 2

multiple interactions
increases uptake
increases transport

ISO

5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Novobiocin inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow]

PMID:31348918 PMID:32305507

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493

metamizole sodium

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

corticotropin releasing hormone

multiple interactions

EXP

Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [Lipopolysaccharides results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]

NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386

G

epidermal growth factor receptor

multiple interactions

EXP

Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein]

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

interleukin 1 beta

multiple interactions

EXP

Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions

EXP

Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

prostaglandin-endoperoxide synthase 1

decreases activity

ISO

Dipyrone analog results in decreased activity of PTGS1 protein; Dipyrone results in decreased activity of PTGS1 protein

PMID:12242329 PMID:16141368

NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990

G

transforming growth factor alpha

multiple interactions

EXP

Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein]

NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339

G

tumor necrosis factor

multiple interactions

EXP

Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

iodotyrosine deiodinase

multiple interactions

ISO

Direct Red 81 inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386

sodium disulfite

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 9

increases expression

EXP

sodium metabisulfite results in increased expression of ABCC9 mRNA; sodium metabisulfite results in increased expression of ABCC9 protein

PMID:25463229 PMID:26015265

NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348

G

BCL2 associated X, apoptosis regulator

increases expression

ISO

sodium metabisulfite results in increased expression of BAX mRNA

PMID:33957602 PMID:35067933

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

decreases expression

ISO

sodium metabisulfite results in decreased expression of BCL2 mRNA

PMID:33957602 PMID:35067933

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

calcium voltage-gated channel subunit alpha1 C

decreases expression

EXP

sodium metabisulfite results in decreased expression of CACNA1C mRNA; sodium metabisulfite results in decreased expression of CACNA1C protein

PMID:25463229 PMID:26015265

NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762

G

calcium voltage-gated channel subunit alpha1 D

decreases expression

EXP

sodium metabisulfite results in decreased expression of CACNA1D mRNA; sodium metabisulfite results in decreased expression of CACNA1D protein

PMID:25463229 PMID:26015265

NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692

G

caspase 3

multiple interactions
increases activity

EXP
ISO

GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein]
sodium metabisulfite results in increased expression of and results in increased cleavage of and results in increased activity of CASP3 protein

PMID:25486021 PMID:33957602

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 8

increases expression
multiple interactions
increases activity

ISO
EXP

sodium metabisulfite results in increased expression of CASP8 mRNA
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein]

PMID:25486021 PMID:33957602

NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699

G

caspase 9

increases expression
multiple interactions
increases activity

ISO
EXP

sodium metabisulfite results in increased expression of CASP9 mRNA
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein]

PMID:25486021 PMID:33957602

Ensembl chr 5:159,391,188...159,409,648

G

DNA-damage inducible transcript 3

increases expression

EXP

sodium metabisulfite results in increased expression of DDIT3 protein

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

ghrelin and obestatin prepropeptide

multiple interactions

EXP

GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein]

NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969

G

heat shock protein family A (Hsp70) member 5

increases expression

EXP

sodium metabisulfite results in increased expression of HSPA5 protein

NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790

G

potassium inwardly-rectifying channel, subfamily J, member 11

increases expression

EXP

sodium metabisulfite results in increased expression of KCNJ11 mRNA; sodium metabisulfite results in increased expression of KCNJ11 protein

PMID:25463229 PMID:26015265

NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169

G

potassium inwardly-rectifying channel, subfamily J, member 8

increases expression

EXP

sodium metabisulfite results in increased expression of KCNJ8 mRNA; sodium metabisulfite results in increased expression of KCNJ8 protein

NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531

G

potassium calcium-activated channel subfamily M alpha 1

increases expression

EXP

sodium metabisulfite results in increased expression of KCNMA1 mRNA; sodium metabisulfite results in increased expression of KCNMA1 protein

NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117

G

potassium calcium-activated channel subfamily M regulatory beta subunit 1

increases expression

EXP

sodium metabisulfite results in increased expression of KCNMB1 mRNA; sodium metabisulfite results in increased expression of KCNMB1 protein

NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204

G

nuclear factor kappa B subunit 1

decreases expression

ISO

sodium metabisulfite results in decreased expression of NFKB1 mRNA

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

RELA proto-oncogene, NF-kB subunit

increases phosphorylation

EXP

sodium metabisulfite results in increased phosphorylation of RELA protein

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

sodium voltage-gated channel alpha subunit 1

increases expression

EXP

sodium metabisulfite results in increased expression of SCN1A protein

NCBI chr 3:71,360,840...71,479,870
Ensembl chr 3:71,360,841...71,479,791

G

tumor protein p53

decreases expression

ISO

sodium metabisulfite results in decreased expression of TP53 mRNA

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

xanthine dehydrogenase

multiple interactions
increases activity

EXP

GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein]

NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350

sodium dodecyl sulfate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arylacetamide deacetylase-like 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of AADACL2 mRNA

NCBI chr 2:146,273,344...146,293,953
Ensembl chr 2:146,273,344...146,293,953

G

ATP binding cassette subfamily A member 12

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA

NCBI chr 9:80,272,121...80,445,340
Ensembl chr 9:80,272,127...80,445,340

G

ATP binding cassette subfamily A member 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ABCA6 mRNA

NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899

G

ATP binding cassette subfamily B member 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA

NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526

G

ATP binding cassette subfamily C member 1

multiple interactions

ISO

Sodium Dodecyl Sulfate inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ABCC2 mRNA

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ABCC3 mRNA

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

acetyl-CoA carboxylase beta

affects response to substance

ISO

ACACB SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214

G

atypical chemokine receptor 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ACKR3 mRNA

NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214

G

ADAM metallopeptidase with thrombospondin type 1, motif 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ADAMTS3 mRNA

NCBI chr14:18,515,249...18,721,887
Ensembl chr14:18,515,249...18,721,887

G

ArfGAP with dual PH domains 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ADAP2 mRNA

NCBI chr10:65,635,891...65,665,019
Ensembl chr10:65,622,434...65,664,022

G

adhesion G protein-coupled receptor E5

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA

NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641

G

adhesion G protein-coupled receptor G2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ADGRG2 mRNA

NCBI chr X:38,106,067...38,231,286
Ensembl chr X:38,106,067...38,231,331

G

adrenoceptor beta 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ADRB2 mRNA

NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803

G

adenylosuccinate synthase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ADSS2 mRNA

NCBI chr13:92,301,302...92,331,638
Ensembl chr13:92,301,302...92,331,638

G

aryl hydrocarbon receptor

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of AHR mRNA

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

allograft inflammatory factor 1

affects response to substance

ISO

AIF1 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339

G

adenylate kinase 8

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of AK8 mRNA

NCBI chr 3:32,426,892...32,542,432
Ensembl chr 3:32,426,421...32,542,431

G

aldo-keto reductase family 1 member B1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of AKR1B1 mRNA

NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315

G

aldo-keto reductase family 1 member B10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA

PMID:20566472 PMID:30806763

NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847

G

aldo-keto reductase family 1, member C1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of AKR1C1 mRNA

NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247

G

aldo-keto reductase family 1, member C2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA

NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686

G

aldo-keto reductase family 1, member C3

increases expression
decreases expression

ISO
EXP

Sodium Dodecyl Sulfate results in increased expression of AKR1C3 mRNA
Sodium Dodecyl Sulfate results in decreased expression of AKR1C3 mRNA
Sodium Dodecyl Sulfate results in decreased expression of AKR1C18 mRNA

PMID:12815608 PMID:20566472 PMID:31734321

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

AKT serine/threonine kinase 1

increases phosphorylation

ISO

Sodium Dodecyl Sulfate results in increased phosphorylation of AKT1 protein

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

aldehyde dehydrogenase 3 family, member B2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA

NCBI chr 1:210,679,749...210,694,187
Ensembl chr 1:210,675,302...210,694,155

G

aldehyde dehydrogenase 3 family, member B3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA

NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879

G

arachidonate 5-lipoxygenase activating protein

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ALOX5AP mRNA

NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038

G

angiopoietin-like 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ANGPTL4 mRNA

NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681

G

ankyrin repeat domain containing 50

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ANKRD50 mRNA

NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340

G

adaptor related protein complex 4 subunit sigma 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of AP4S1 mRNA

NCBI chr 6:74,863,742...74,916,907
Ensembl chr 6:74,868,558...74,912,406

G

amphiregulin

increases secretion

ISO

Sodium Dodecyl Sulfate results in increased secretion of AREG protein

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

ARF GTPase activating protein 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ARFGAP2 mRNA

NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247

G

Rho GDP dissociation inhibitor beta

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA

NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068

G

ADP-ribosyltransferase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ART3 mRNA

NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806

G

asparagine synthetase (glutamine-hydrolyzing)

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ASNS mRNA

NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050

G

assembly factor for spindle microtubules

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ASPM mRNA

NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489

G

ASXL transcriptional regulator 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ASXL1 mRNA

NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:162,273,828...162,341,742

G

activating transcription factor 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ATF3 mRNA

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750

G

autophagy related 9B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ATG9B mRNA

NCBI chr 4:11,678,548...11,686,097
Ensembl chr 4:11,678,299...11,686,079

G

ATPase H+/K+ transporting non-gastric alpha2 subunit

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ATP12A mRNA

NCBI chr15:34,559,209...34,583,866
Ensembl chr15:34,559,209...34,583,866

G

ATP synthase peripheral stalk subunit d

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ATP5PD protein

NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954

G

beta-1,3-glucuronyltransferase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of B3GAT2 mRNA

NCBI chr 9:33,663,482...33,746,466
Ensembl chr 9:33,663,482...33,746,466

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA

NCBI chr16:18,434,114...18,444,851
Ensembl chr16:18,435,378...18,444,738

G

BMP and activin membrane-bound inhibitor

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of BAMBI mRNA

NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247

G

butyrylcholinesterase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of BCHE mRNA

NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760

G

brain expressed X-linked 5 like 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of BEX5 mRNA

NCBI chr 1:119,181,370...119,202,904

G

BICD cargo adaptor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of BICD1 mRNA

NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:184,210,363...184,357,391

G

biliverdin reductase A

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of BLVRA protein

NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785

G

biliverdin reductase B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA

NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225

G

BMP/retinoic acid inducible neural specific 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of BRINP1 mRNA

NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256

G

similar to human chromosome 18 open reading frame 21

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RMP24 mRNA

NCBI chr18:16,054,038...16,062,645
Ensembl chr18:16,053,880...16,064,239

G

similar to human chromosome 16 open reading frame 46

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of C16ORF46 mRNA

NCBI chr19:61,931,114...61,941,517
Ensembl chr19:61,931,116...61,941,517

G

complement C1r

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of C1R mRNA

NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714

G

complement C2

affects response to substance

ISO

C2 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740

G

similar to human chromosome 5 open reading frame 34

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of C5ORF34 mRNA

NCBI chr 2:53,287,353...53,309,804
Ensembl chr 2:53,287,957...53,309,806

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CAMK2N1 mRNA

NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058

G

calcium activated nucleotidase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CANT1 mRNA

NCBI chr10:104,135,676...104,148,854
Ensembl chr10:104,135,682...104,148,698

G

calpain, small subunit 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CAPNS2 mRNA

NCBI chr19:30,277,324...30,278,266

G

carbonic anhydrase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CA2 mRNA

NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064

G

Cbl proto-oncogene like 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CBLL1 mRNA

NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880

G

coiled-coil domain containing 8

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CCDC8 mRNA

NCBI chr 1:86,807,607...86,810,935
Ensembl chr 1:86,806,942...86,814,204

G

C-C motif chemokine ligand 2

decreases expression
multiple interactions

ISO

Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]

PMID:20713136 PMID:36416909

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

C-C motif chemokine ligand 20

multiple interactions
increases expression
increases secretion

ISO

IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]
Sodium Dodecyl Sulfate results in increased expression of CCL20 mRNA

PMID:15679580 PMID:30806763 PMID:31734321

NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736

G

C-C motif chemokine ligand 27

increases secretion

ISO

Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein

NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:61,737,261...61,743,522

G

C-C motif chemokine ligand 3

multiple interactions

ISO

Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]

NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439

G

C-C motif chemokine ligand 4

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CCL4 mRNA

NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722

G

C-C motif chemokine ligand 5

increases secretion
increases expression

ISO

Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein
Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA

PMID:16099135 PMID:31734321

NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884

G

cellular communication network factor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CCN1 mRNA

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cellular communication network factor 2

decreases expression
increases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CCN2 mRNA
Sodium Dodecyl Sulfate results in increased expression of CCN2 mRNA

PMID:25377654 PMID:31734321

NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976

G

C-C motif chemokine receptor 5

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CCR5 mRNA

NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594

G

C-C motif chemokine receptor 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CCR7 mRNA

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501

G

CD40 molecule

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CD40 mRNA

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD86 molecule

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CD86 protein

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

cell division cycle 25A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CDC25A mRNA

NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188

G

cadherin 26

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CDH26 mRNA

NCBI chr 3:185,898,185...185,950,892
Ensembl chr 3:185,898,431...185,950,892

G

cyclin-dependent kinase inhibitor 1C

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CDKN1C mRNA

NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498

G

CUGBP, Elav-like family member 6

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CELF6 mRNA

NCBI chr 8:68,870,902...68,901,863
Ensembl chr 8:68,871,093...68,901,863

G

ceramide kinase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CERK mRNA

NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570

G

ceramide synthase 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CERS3 mRNA

PMID:29155129 PMID:31734321

NCBI chr 1:129,728,136...129,833,182
Ensembl chr 1:129,677,781...129,833,181

G

cofilin 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CFL1 mRNA; Sodium Dodecyl Sulfate results in increased expression of CFL1 protein

NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353

G

ChaC glutathione-specific gamma-glutamylcyclotransferase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CHAC1 mRNA

NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361

G

carbohydrate sulfotransferase 11

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CHST11 mRNA

NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

cardiotrophin-like cytokine factor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CLCF1 mRNA

NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064

G

claudin 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CLDN7 mRNA

NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905

G

CDC-like kinase 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CLK3 mRNA

NCBI chr 8:67,048,121...67,063,192
Ensembl chr 8:67,048,123...67,062,881

G

calmin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CLMN mRNA

NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027

G

chemerin chemokine-like receptor 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CMKLR2 mRNA

NCBI chr 9:72,077,164...72,111,979
Ensembl chr 9:72,078,608...72,116,257

G

CKLF-like MARVEL transmembrane domain containing 8

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CMTM8 mRNA

NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276

G

cornifelin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CNFN mRNA; Sodium Dodecyl Sulfate results in increased expression of CNFN protein

NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556

G

cyclin and CBS domain divalent metal cation transport mediator 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CNNM2 mRNA

NCBI chr 1:255,585,063...255,709,455
Ensembl chr 1:255,585,095...255,704,849

G

collagen type XI alpha 1 chain

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of COL11A1 mRNA

NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264

G

collagen type II alpha 1 chain

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of COL2A1 mRNA

NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627

G

cytochrome c oxidase assembly factor COX19

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of COX19 mRNA

NCBI chr12:20,417,389...20,426,868
Ensembl chr12:20,417,341...20,426,868

G

carnitine palmitoyltransferase 1A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CPT1A mRNA

NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326

G

cellular retinoic acid binding protein 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CRABP2 mRNA

NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385

G

cysteine-rich C-terminal 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CRCT1 mRNA

NCBI chr 2:181,329,392...181,330,877
Ensembl chr 2:181,329,392...181,330,877

G

cAMP responsive element binding protein 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CREB1 mRNA

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

CREB binding protein

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CREBBP mRNA

NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266

G

cysteine-rich with EGF-like domains 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CRELD2 mRNA

NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228

G

cornulin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CRNN mRNA

NCBI chr 2:181,427,384...181,432,142
Ensembl chr 2:181,429,481...181,431,993

G

cytotoxic and regulatory T cell molecule

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CRTAM mRNA

NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472

G

colony stimulating factor 2

increases expression
increases secretion

ISO

Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA
Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein

PMID:11378323 PMID:22245253

NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031

G

colony stimulating factor 2 receptor subunit beta

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CSF2RB mRNA

NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654

G

cysteine and serine rich nuclear protein 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA

NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469

G

CTD nuclear envelope phosphatase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CTDNEP1 mRNA

NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852

G

cathepsin H

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CTSH mRNA

NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181

G

cullin 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CUL7 mRNA

NCBI chr 9:21,816,703...21,830,344
Ensembl chr 9:21,816,703...21,830,344

G

C-X-C motif chemokine ligand 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA

NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811

G

C-X-C motif chemokine ligand 10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA

PMID:17936526 PMID:23445166 PMID:31734321

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 14

decreases expression
multiple interactions

ISO

Sodium Dodecyl Sulfate results in decreased expression of CXCL14 mRNA; Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]; WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]

NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172

G

C-X-C motif chemokine ligand 2

decreases expression
increases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CXCL2 protein
Sodium Dodecyl Sulfate results in increased expression of CXCL2 protein

NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255

G

C-X-C motif chemokine ligand 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA

PMID:28826779 PMID:31734321

NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624

G

C-X-C motif chemokine receptor 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CXCR4 mRNA

NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459

G

cytochrome b561 family, member A3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CYB561A3 mRNA

NCBI chr 1:216,641,108...216,662,495
Ensembl chr 1:216,651,128...216,662,492

G

cytochrome b5 reductase 4

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CYB5R4 mRNA

NCBI chr 8:96,860,415...96,925,789
Ensembl chr 8:96,861,090...96,926,094

G

cytochrome P450, family 1, subfamily a, polypeptide 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of CYP1A1 mRNA

PMID:20491607 PMID:30806763

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 27, subfamily a, polypeptide 1

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of CYP27A1 mRNA

NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215

G

cytochrome P450, family 2, subfamily b, polypeptide 2

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of CYP2B2 mRNA

NCBI chr 1:90,722,243...90,736,272

G

cytochrome P450, family 4, subfamily f, polypeptide 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of CYP4F12 mRNA

NCBI chr 7:12,661,357...12,672,952
Ensembl chr 7:12,661,359...12,672,612

G

cytochrome P450, family 51

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA

NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450

G

death associated protein-like 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DAPL1 mRNA

NCBI chr 3:64,369,734...64,389,677
Ensembl chr 3:64,369,546...64,389,677

G

dicarbonyl and L-xylulose reductase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DCXR mRNA

NCBI chr10:106,504,730...106,506,619

G

DNA-damage inducible transcript 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DDIT3 mRNA

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DEXD/H-box helicase 60

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DDX60 mRNA

NCBI chr16:33,087,940...33,208,843
Ensembl chr16:33,087,988...33,208,839

G

delta(4)-desaturase, sphingolipid 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DEGS1 mRNA

NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302

G

DENN domain containing 2D

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DENND2D mRNA

NCBI chr 2:196,661,465...196,680,505
Ensembl chr 2:196,661,345...196,682,397

G

DNA fragmentation factor subunit beta

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DFFB mRNA

NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225

G

7-dehydrocholesterol reductase

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dihydrodiol dehydrogenase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DHDH mRNA

NCBI chr 1:105,088,108...105,102,560
Ensembl chr 1:105,090,309...105,101,567

G

disco-interacting protein 2 homolog C

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DIP2C mRNA

NCBI chr17:65,338,711...65,724,111
Ensembl chr17:65,338,711...65,723,344

G

DnaJ heat shock protein family (Hsp40) member B4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA

NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042

G

docking protein 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DOK7 mRNA

NCBI chr14:79,890,051...79,924,081
Ensembl chr14:79,891,367...79,932,252

G

dihydropyrimidinase-like 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DPYSL2 mRNA

NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065

G

desmocollin 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DSC1 mRNA

NCBI chr18:11,774,711...11,831,868
Ensembl chr18:11,775,010...11,803,522

G

desmoglein 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of DSG1 mRNA

NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451

G

dual specificity phosphatase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DUSP1 mRNA

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA

NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809

G

E2F transcription factor 8

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of E2F8 mRNA

NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009

G

endothelin 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

EGF containing fibulin extracellular matrix protein 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of EFEMP2 mRNA

NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739

G

early growth response 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of EGR1 mRNA

PMID:25377654 PMID:31734321

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

eukaryotic translation initiation factor 2 alpha kinase 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of EIF2AK1 mRNA

NCBI chr12:15,824,431...15,858,266
Ensembl chr12:15,825,124...15,858,281

G

ELOVL fatty acid elongase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ELOVL1 mRNA

NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352

G

epithelial membrane protein 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of EMP1 mRNA

NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365

G

erythroblast membrane associated protein (Scianna blood group)

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ERMAP mRNA

NCBI chr 5:138,074,155...138,088,340
Ensembl chr 5:138,065,824...138,087,015

G

ezrin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of EZR mRNA; Sodium Dodecyl Sulfate results in increased expression of EZR protein

NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573

G

coagulation factor VIII

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of F8 mRNA

NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683

G

fatty acid binding protein 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FABP3 mRNA

NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid binding protein 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FABP4 mRNA

NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972

G

fumarylacetoacetate hydrolase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FAH mRNA

NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046

G

family with sequence similarity 171, member A1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FAM171A1 mRNA

NCBI chr17:79,933,742...80,057,495
Ensembl chr17:79,934,050...80,057,495

G

family with sequence similarity 83, member C

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FAM83C mRNA

NCBI chr 3:164,792,258...164,799,882
Ensembl chr 3:164,793,105...164,799,995

G

FA complementation group L

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FANCL mRNA

NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297

G

F-box protein 5

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FBXO5 mRNA

NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781

G

ferrochelatase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FECH mRNA

NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546

G

FKBP prolyl isomerase 11

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FKBP11 mRNA

NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123

G

filaggrin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FLG mRNA; Sodium Dodecyl Sulfate results in increased expression of FLG protein

NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968

G

filaggrin 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FLG2 mRNA

G

fibronectin 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FN1 mRNA

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

Fos proto-oncogene, AP-1 transcription factor subunit

decreases expression
increases expression

EXP
ISO

Sodium Dodecyl Sulfate results in decreased expression of FOS mRNA
Sodium Dodecyl Sulfate results in increased expression of FOS mRNA

PMID:12815608 PMID:31734321

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

forkhead box A2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FOXA2 mRNA

NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757

G

forkhead box N1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FOXN1 mRNA

NCBI chr10:63,749,461...63,778,468
Ensembl chr10:63,749,461...63,771,771

G

forkhead box O4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FOXO4 mRNA

NCBI chr X:70,425,218...70,432,120
Ensembl chr X:70,425,563...70,432,120

G

follistatin

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FST mRNA

NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491

G

ferritin light chain 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of FTL mRNA

NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

frizzled class receptor 7

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of FZD7 mRNA

NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585

G

G0/G1switch 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of G0S2 mRNA

NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293

G

glucose-6-phosphate dehydrogenase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of G6PD mRNA

NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144

G

growth arrest and DNA-damage-inducible, beta

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GADD45B mRNA

NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718

G

galanin and GMAP prepropeptide

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GAL mRNA

NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229

G

glyceraldehyde-3-phosphate dehydrogenase

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of GAPDH mRNA

NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377

G

growth arrest-specific 2 like 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GAS2L3 mRNA

NCBI chr 7:25,690,929...25,726,806
Ensembl chr 7:25,693,660...25,716,942

G

gastrin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GAST mRNA

NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880

G

guanylate binding protein 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GBP1 mRNA

NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802
Ensembl chr 2:234,190,708...234,206,802

G

glutamate-cysteine ligase, catalytic subunit

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA

NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893

G

glutamate cysteine ligase, modifier subunit

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA

NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003

G

GTP binding protein overexpressed in skeletal muscle

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GEM mRNA

NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542

G

gap junction protein, alpha 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GJA1 mRNA

NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689

G

gap junction protein, beta 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GJB1 mRNA

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843

G

gap junction protein, beta 2

increases expression

EXP

Sodium Dodecyl Sulfate results in increased expression of GJB2 mRNA

NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877

G

gap junction protein, beta 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GJB6 mRNA

NCBI chr15:35,400,147...35,410,649
Ensembl chr15:35,398,770...35,410,849

G

gap junction protein, gamma 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GJC1 mRNA

NCBI chr10:88,262,840...88,285,646
Ensembl chr10:88,249,489...88,285,853

G

glycine decarboxylase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GLDC mRNA

NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604

G

G patch domain containing 11

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GPATCH11 mRNA

NCBI chr 6:21,982,074...21,995,562
Ensembl chr 6:21,985,202...21,995,381

G

growth factor receptor bound protein 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GRB7 mRNA

NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382

G

grainyhead-like transcription factor 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA

NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264

G

glutathione-disulfide reductase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of GSR mRNA

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

hyaluronan synthase 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HAS3 mRNA

NCBI chr19:51,668,276...51,691,042

G

hematopoietic cell specific Lyn substrate 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA

NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HERC6 mRNA

NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993

G

hes-related family bHLH transcription factor with YRPW motif 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HEY1 mRNA

NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:95,002,943...95,007,624

G

histone cluster 1 H2A family member F

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of H2AC8 mRNA

NCBI chr17:41,807,261...41,807,653

G

histone cluster 1, H2bc

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of H2BC21 mRNA

NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020

G

histone cluster 2 H2B family member E

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of H2BC11 mRNA

NCBI chr 2:186,469,452...186,471,899

G

hexokinase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HK2 mRNA

NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275

G

heme oxygenase 1

increases expression
affects expression

ISO
EXP

Sodium Dodecyl Sulfate results in increased expression of HMOX1 mRNA
Sodium Dodecyl Sulfate affects the expression of HMOX1 mRNA

PMID:12815608 PMID:20566472 PMID:22954530 PMID:30806763 PMID:31734321

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

heme oxygenase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HMOX2 mRNA

NCBI chr10:11,303,512...11,337,640
Ensembl chr10:11,303,512...11,318,800

G

heterogeneous nuclear ribonucleoprotein A/B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HNRNPAB protein

NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307

G

heterogeneous nuclear ribonucleoprotein L-like

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HNRNPLL mRNA

NCBI chr 6:20,720,013...20,752,803
Ensembl chr 6:20,722,184...20,752,802

G

hippocalcin-like 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HPCAL1 mRNA

NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353

G

heparan sulfate-glucosamine 3-sulfotransferase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HS3ST2 mRNA

NCBI chr 1:185,387,445...185,508,700
Ensembl chr 1:185,386,761...185,508,700

G

HscB mitochondrial iron-sulfur cluster co-chaperone

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of HSCB mRNA

NCBI chr12:51,481,318...51,491,689
Ensembl chr12:51,481,326...51,501,507

G

heat shock transcription factor family, X-linked member 3 like

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA

NCBI chr X:151,167,783...151,170,000

G

heat shock protein family A (Hsp70) member 6 like, pseudogene 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HSPA6 mRNA

NCBI chr13:85,805,911...85,807,052

G

heat shock protein family B (small) member 1

decreases expression
multiple interactions
increases expression
decreases phosphorylation

EXP
ISO

Sodium Dodecyl Sulfate results in decreased expression of HSPB1 mRNA
Sodium Dodecyl Sulfate results in decreased expression of and affects the localization of HSPB1 protein
Sodium Dodecyl Sulfate results in increased expression of HSPB1 mRNA; Sodium Dodecyl Sulfate results in increased expression of HSPB1 protein
Sodium Dodecyl Sulfate results in decreased phosphorylation of HSPB1 protein

PMID:12815608 PMID:20332019 PMID:21469165

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

heat shock protein family B (small) member 8

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HSPB8 mRNA

NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937

G

heat shock protein family H (Hsp110) member 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of HSPH1 mRNA

NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891

G

inhibitor of Bruton tyrosine kinase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IBTK mRNA

NCBI chr 8:95,505,630...95,579,435
Ensembl chr 8:95,505,630...95,578,301

G

intercellular adhesion molecule 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ICAM1 mRNA

NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617

G

isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IDH3A protein

NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IDI1 protein

NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524

G

interferon-induced protein 35

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA

NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750

G

interferon gamma

multiple interactions
increases expression

ISO

[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein
Sodium Dodecyl Sulfate results in increased expression of IFNG protein

PMID:12062936 PMID:28826779

NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216

G

insulin-like growth factor 2 receptor

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IGF2R mRNA

NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265

G

interleukin 12B

multiple interactions

ISO

Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]

NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194

G

interleukin 13 receptor subunit alpha 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL13RA2 mRNA

NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455

G

interleukin 16

increases secretion

ISO

Sodium Dodecyl Sulfate results in increased secretion of IL16 protein

NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023

G

interleukin 17A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL17A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL17A protein

NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331

G

interleukin 1 alpha

multiple interactions
decreases expression
increases expression
increases secretion

ISO

IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]; Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of IL1A protein
Sodium Dodecyl Sulfate results in decreased expression of IL1A protein
Sodium Dodecyl Sulfate results in increased expression of IL1A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL1A protein
Sodium Dodecyl Sulfate results in increased secretion of IL1A protein

PMID:11378323 PMID:12781210 PMID:15679580 PMID:19878710 PMID:21469165 More...

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 beta

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL1B mRNA

PMID:9856837 PMID:11378323 PMID:33715048

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 1 receptor type 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374

G

interleukin 1 receptor-like 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL1RL1 mRNA

NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891

G

interleukin 2

multiple interactions
increases expression

ISO

[Sodium Dodecyl Sulfate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein
Sodium Dodecyl Sulfate results in increased expression of IL2 protein

PMID:15588918 PMID:22381623

NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672

G

interleukin 24

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL24 protein

NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760

G

interleukin 33

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IL33 mRNA

NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901

G

interleukin 36, gamma

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL36G mRNA

NCBI chr 3:27,346,675...27,352,839
Ensembl chr 3:27,346,670...27,352,834

G

interleukin 36 receptor antagonist

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL36RN mRNA

NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:27,442,709...27,449,306

G

interleukin 4

multiple interactions
increases expression

ISO

[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein
Sodium Dodecyl Sulfate results in increased expression of IL4 mRNA

PMID:12062936 PMID:28826779

NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549

G

interleukin 6

increases expression
multiple interactions

ISO

Sodium Dodecyl Sulfate results in increased expression of IL6 mRNA; Sodium Dodecyl Sulfate results in increased expression of IL6 protein
[Tetradecanoylphorbol Acetate co-treated with Sodium Dodecyl Sulfate] results in increased expression of and results in increased secretion of IL6 protein

PMID:11378323 PMID:24964617 PMID:33839235

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

interleukin 7 receptor

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027

G

inosine monophosphate dehydrogenase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IMPDH2 mRNA

NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873

G

inositol 1,4,5-triphosphate receptor associated 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IRAG1 mRNA

NCBI chr 1:174,416,383...174,528,913
Ensembl chr 1:174,416,385...174,528,851

G

iroquois homeobox 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of IRX3 mRNA

NCBI chr19:31,384,803...31,388,241
Ensembl chr19:31,384,833...31,388,238

G

inositol 1,4,5-trisphosphate receptor, type 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ITPR1 mRNA

NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504

G

involucrin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of IVL mRNA; Sodium Dodecyl Sulfate results in increased expression of IVL protein

NCBI chr 2:180,842,307...180,854,646
Ensembl chr 2:180,842,307...180,846,578

G

iodotyrosine deiodinase

multiple interactions

ISO

Sodium Dodecyl Sulfate inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386

G

junctophilin 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA

NCBI chr 3:172,414,246...172,478,678
Ensembl chr 3:172,414,256...172,478,348

G

JPX transcript, XIST activator

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of JPX mRNA

NCBI chr X:72,577,163...72,730,887

G

Jrk helix-turn-helix protein

affects expression

ISO

Sodium Dodecyl Sulfate affects the expression of JRK mRNA

NCBI chr 7:108,479,646...108,484,329
Ensembl chr 7:108,453,398...108,495,813

G

JunB proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of JUNB mRNA

NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218

G

potassium channel tetramerization domain containing 11

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KCTD11 mRNA

NCBI chr10:55,101,292...55,103,455
Ensembl chr10:55,100,801...55,103,583

G

KIAA1549 homolog

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KIAA1549 mRNA

NCBI chr 4:67,807,635...67,935,303
Ensembl chr 4:67,811,803...67,935,360

G

KIAA1958 homolog

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KIAA1958 mRNA

NCBI chr 5:79,286,708...79,432,859
Ensembl chr 5:79,286,708...79,432,859

G

kinesin family member 20B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KIF20B mRNA

NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451

G

kinesin light chain 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KLC2 mRNA

NCBI chr 1:211,843,927...211,854,160
Ensembl chr 1:211,843,929...211,854,160

G

kelch-like family member 21

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA

NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276

G

kallikrein related-peptidase 10

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KLK10 mRNA

NCBI chr 1:103,371,638...103,375,918
Ensembl chr 1:103,371,638...103,375,918

G

killer cell lectin like receptor G2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KLRG2 mRNA

NCBI chr 4:68,314,347...68,341,759
Ensembl chr 4:68,330,660...68,341,043

G

kininogen 1

increases expression

EXP

Sodium Dodecyl Sulfate results in increased expression of KNG1 mRNA

NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148

G

keratin 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KRT1 mRNA

NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:134,855,313...134,860,537

G

keratin 18

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KRT18 mRNA

NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848

G

keratin 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of KRT2 mRNA

NCBI chr 7:134,819,584...134,826,736
Ensembl chr 7:134,819,584...134,827,011

G

keratin 8

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KRT8 mRNA

NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403

G

keratin 80

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KRT80 mRNA

NCBI chr 7:134,341,951...134,363,872
Ensembl chr 7:134,341,956...134,364,211

G

keratin 9

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KRT9 protein

NCBI chr10:85,621,360...85,627,626
Ensembl chr10:85,621,360...85,627,626

G

laminin subunit beta 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LAMB1 mRNA

NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:53,563,073...53,630,760

G

lysosomal-associated membrane protein 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LAMP3 mRNA

NCBI chr11:94,657,817...94,726,451
Ensembl chr11:94,661,399...94,726,195

G

late cornified envelope 1E

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LCE1E mRNA

NCBI chr 2:181,157,709...181,159,042
Ensembl chr 2:181,157,709...181,159,042

G

lipocalin 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA

NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842

G

low density lipoprotein receptor class A domain containing 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LDLRAD3 mRNA

NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368

G

LEM domain containing 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LEMD1 mRNA

NCBI chr13:46,183,860...46,250,105
Ensembl chr13:46,218,085...46,250,562

G

lipoic acid synthetase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LIAS mRNA

NCBI chr14:43,230,369...43,247,469
Ensembl chr14:43,230,375...43,247,423

G

LIF, interleukin 6 family cytokine

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LIF protein

NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053

G

DNA ligase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LIG3 mRNA

NCBI chr10:68,215,371...68,238,705
Ensembl chr10:68,215,407...68,238,704

G

loricrin cornified envelope precursor protein

decreases expression
increases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LORICRIN protein
Sodium Dodecyl Sulfate results in increased expression of LORICRIN mRNA

PMID:25240866 PMID:33839235

NCBI chr 2:180,253,674...180,256,572
Ensembl chr 2:180,253,674...180,256,572

G

leucine rich repeat containing 8 VRAC subunit E

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LRRC8E mRNA

NCBI chr12:7,376,103...7,387,250
Ensembl chr12:7,380,585...7,387,249

G

lactotransferrin

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA

NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189

G

LYN proto-oncogene, Src family tyrosine kinase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of LYN mRNA

NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:21,437,084...21,554,461

G

lysophospholipase 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of LYPLA1 protein

NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:19,477,409...19,506,522

G

MAF bZIP transcription factor F

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MAFF mRNA

NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147

G

MAF bZIP transcription factor G

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MAFG mRNA

NCBI chr10:106,401,633...106,410,159

G

MAGE family member H1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MAGEH1 mRNA

NCBI chr X:21,725,709...21,726,965
Ensembl chr X:21,718,669...21,727,219

G

mitogen-activated protein kinase kinase kinase 1

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA

NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897

G

mitogen-activated protein kinase kinase kinase 8

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MAP3K8 mRNA

NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452

G

mitogen activated protein kinase 1

increases phosphorylation
multiple interactions

ISO

Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein]

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen activated protein kinase 14

increases phosphorylation

ISO

Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK14 protein

NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294

G

mitogen activated protein kinase 3

increases phosphorylation
multiple interactions

ISO

Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein]

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

MARCKS-like 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MARCKSL1 mRNA

NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:147,134,514...147,138,417

G

metallo-beta-lactamase domain containing 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MBLAC1 mRNA

NCBI chr12:22,185,142...22,186,404
Ensembl chr12:22,184,917...22,200,899

G

multiple C2 and transmembrane domain containing 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MCTP1 mRNA

NCBI chr 2:7,798,968...8,493,596
Ensembl chr 2:7,803,382...8,493,596

G

malic enzyme 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ME1 mRNA

NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275

G

mesenchyme homeobox 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MEOX1 mRNA

NCBI chr10:87,318,668...87,338,169
Ensembl chr10:87,318,695...87,337,976

G

MHC class I polypeptide-related sequence B

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MICB mRNA

NCBI chr 1:87,623,826...87,641,075
Ensembl chr 1:87,623,826...87,640,872

G

microRNA 205

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of MIR205 mRNA

NCBI chr13:107,564,535...107,564,642

G

metabolism of cobalamin associated A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA

NCBI chr19:45,523,352...45,553,602
Ensembl chr19:45,523,379...45,555,375

G

matrix metallopeptidase 10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MMP10 mRNA

PMID:30806763 PMID:31734321

NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613

G

matrix metallopeptidase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MMP3 mRNA

NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826

G

modulator of smoothened

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of MOSMO mRNA

NCBI chr 1:184,648,985...184,719,820
Ensembl chr 1:184,648,985...184,719,820

G

mitochondrial ribosomal protein L38

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of MRPL38 mRNA

NCBI chr10:101,864,242...101,871,048
Ensembl chr10:101,863,318...101,871,048

G

methionine sulfoxide reductase B2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of MSRB2 mRNA

NCBI chr17:86,882,750...86,908,392
Ensembl chr17:86,882,394...86,908,391

G

metallothionein 1A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MT1A mRNA

NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200

G

metallothionein 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MT2A mRNA

NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709

G

mucin 15, cell surface associated

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of MUC15 mRNA

NCBI chr 3:117,749,161...117,761,466
Ensembl chr 3:117,749,324...117,762,101

G

max dimerization protein 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MXD1 mRNA

NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129

G

MYC proto-oncogene, bHLH transcription factor

increases expression

EXP

Sodium Dodecyl Sulfate results in increased expression of MYC mRNA

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

myelin expression factor 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MYEF2 mRNA

NCBI chr 3:132,791,694...132,827,572
Ensembl chr 3:132,791,694...132,827,523

G

myosin light chain 12A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of MYL12A mRNA

NCBI chr 9:118,338,592...118,346,277
Ensembl chr 9:118,338,604...118,342,634

G

nexilin (F actin binding protein)

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of NEXN mRNA

NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114

G

nuclear factor kappa B subunit 1

affects expression

ISO

Sodium Dodecyl Sulfate affects the expression of NFKB1 mRNA

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

nuclear transcription factor Y subunit alpha

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of NFYA mRNA

NCBI chr 9:20,085,067...20,111,521
Ensembl chr 9:20,085,073...20,111,504

G

nipsnap homolog 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of NIPSNAP2 mRNA

NCBI chr12:32,542,171...32,580,345
Ensembl chr12:32,547,819...32,580,303

G

NLR family, pyrin domain containing 10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of NLRP10 mRNA

NCBI chr 1:172,357,648...172,365,205
Ensembl chr 1:172,357,648...172,365,205

G

NME/NM23 nucleoside diphosphate kinase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of NME2 protein

NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497
Ensembl chr10:11,179,066...11,179,497

G

neuromedin U

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of NMU mRNA

NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632

G

NAD(P)H quinone dehydrogenase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of NQO1 mRNA

PMID:20491607 PMID:20566472

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 4, group A, member 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of NR4A2 mRNA

NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769

G

neurotrophic receptor tyrosine kinase 2

affects response to substance

ISO

NTRK2 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628

G

olfactomedin-like 2A

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of OLFML2A mRNA

NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:43,098,299...43,127,621

G

purinergic receptor P2Y1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of P2RY1 mRNA

NCBI chr 2:147,391,661...147,397,870
Ensembl chr 2:147,390,681...147,398,027

G

PAS domain containing serine/threonine kinase

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of PASK mRNA

NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504

G

PC-esterase domain containing 1A

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PCED1A mRNA

NCBI chr 3:138,049,747...138,076,107
Ensembl chr 3:138,067,891...138,075,146

G

phosphoenolpyruvate carboxykinase 2 (mitochondrial)

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PCK2 mRNA

NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864

G

proprotein convertase subtilisin/kexin type 6

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PCSK6 mRNA

NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128

G

phosphatidylcholine transfer protein

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PCTP mRNA

NCBI chr10:75,305,999...75,351,919
Ensembl chr10:75,305,999...75,326,432

G

pyruvate dehydrogenase E1 subunit alpha 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PDHA1 protein

NCBI chr X:38,509,158...38,522,986
Ensembl chr X:38,509,084...38,522,536

G

period circadian regulator 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PER2 mRNA

NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993

G

peroxisomal biogenesis factor 11 gamma

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PEX11G mRNA

NCBI chr12:6,301,461...6,329,741
Ensembl chr12:6,277,664...6,318,919

G

phosphogluconate dehydrogenase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PGD mRNA

NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029

G

PH domain containing endocytic trafficking adaptor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PHETA1 mRNA

NCBI chr12:40,372,553...40,378,321
Ensembl chr12:40,367,001...40,377,854

G

putative homeodomain transcription factor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PHTF1 mRNA

NCBI chr 2:194,161,343...194,249,925
Ensembl chr 2:194,161,000...194,219,530

G

phosphatidylinositol-5-phosphate 4-kinase type 2 beta

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PIP4K2B mRNA

NCBI chr10:83,202,379...83,231,292
Ensembl chr10:83,197,287...83,231,292

G

pirin

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PIR mRNA

NCBI chr X:33,740,428...33,851,049
Ensembl chr X:33,740,429...33,851,049

G

phosphatidylinositol transfer protein, beta

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PITPNB protein

NCBI chr12:50,909,140...50,958,193
Ensembl chr12:50,909,143...50,958,140

G

piwi-like RNA-mediated gene silencing 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PIWIL2 mRNA

NCBI chr15:51,841,104...51,907,729
Ensembl chr15:51,841,405...51,907,819

G

pejvakin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PJVK mRNA

NCBI chr 3:82,002,106...82,012,273
Ensembl chr 3:82,002,368...82,012,451

G

phospholipase A2 group 4A

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PLA2G4A mRNA

NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641

G

plasminogen activator, urokinase receptor

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

phospholipase D1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PLD1 mRNA

NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245

G

pleckstrin homology domain containing B1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PLEKHB1 mRNA

NCBI chr 1:164,410,901...164,425,216
Ensembl chr 1:164,410,903...164,428,568

G

pleckstrin homology and RhoGEF domain containing G1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PLEKHG1 mRNA

NCBI chr 1:42,612,023...42,841,727
Ensembl chr 1:42,612,122...42,841,719

G

plasminogen receptor with a C-terminal lysine

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PLGRKT mRNA

NCBI chr 1:236,512,574...236,526,858
Ensembl chr 1:236,512,580...236,524,840

G

polo-like kinase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PLK3 mRNA

NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900

G

phospholipid phosphatase 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA

NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667

G

plexin C1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PLXNC1 mRNA

NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092

G

patatin-like phospholipase domain containing 6

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PNPLA6 mRNA

NCBI chr12:6,372,284...6,401,632
Ensembl chr12:6,372,293...6,401,631

G

PPFIA binding protein 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PPFIBP2 mRNA

NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618

G

peptidylprolyl isomerase F

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PPIF mRNA

NCBI chr16:1,264,001...1,270,722
Ensembl chr16:1,263,541...1,316,954

G

protein phosphatase 1 catalytic subunit beta

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PPP1CB protein

NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924

G

protein phosphatase 1, regulatory subunit 10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PPP1R10 mRNA

NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,827,802...2,842,418

G

peroxiredoxin 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PRDX2 mRNA

NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006

G

protein arginine methyltransferase 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PRMT1 mRNA

NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827

G

phosphoribosyl pyrophosphate synthetase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PRPS2 protein

NCBI chr X:30,592,845...30,630,127
Ensembl chr X:30,593,019...30,630,126

G

proline rich 15

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PRR15 mRNA

NCBI chr 4:84,762,357...84,765,403
Ensembl chr 4:84,761,523...84,768,442

G

proline rich 9

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PRR9 mRNA

NCBI chr 2:180,295,095...180,296,461
Ensembl chr 2:180,295,095...180,296,461

G

proline-rich coiled-coil 2A

affects response to substance

ISO

PRRC2A SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr20:3,660,981...3,686,715
Ensembl chr20:3,663,400...3,678,778

G

proline rich and Gla domain 4

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PRRG4 mRNA

NCBI chr 3:111,669,508...111,698,205
Ensembl chr 3:111,673,582...111,698,205

G

serine protease 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PRSS3 mRNA

NCBI chr 4:71,169,749...71,173,223
Ensembl chr 4:71,169,749...71,173,223

G

serine protease 8

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PRSS8 mRNA

NCBI chr 1:191,966,701...191,971,271
Ensembl chr 1:191,966,701...191,971,193

G

proteasome 20S subunit alpha 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PSMA2 protein

NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673

G

proteasome 20S subunit beta 10

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PSMB10 mRNA

NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210

G

proteasome 20S subunit beta 9

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PSMB9 mRNA

NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,668,739...4,674,421

G

proteasome activator subunit 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PSME3 protein

NCBI chr10:86,757,933...86,765,719
Ensembl chr10:86,757,899...86,818,033

G

prostaglandin reductase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PTGR1 mRNA

NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811

G

prostaglandin-endoperoxide synthase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PTGS2 mRNA

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

protein tyrosine phosphatase, receptor type Z1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PTPRZ1 mRNA

NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903

G

pentraxin 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PTX3 mRNA

NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372

G

peroxidasin

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of PXDN mRNA

NCBI chr 6:52,308,347...52,385,943
Ensembl chr 6:52,308,364...52,385,942

G

PYD and CARD domain containing

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of PYCARD protein

NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419

G

RAB33A, member RAS oncogene family

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of RAB33A mRNA

NCBI chr X:132,572,133...132,584,255
Ensembl chr X:132,572,148...132,584,254

G

Rab7b, member RAS oncogene family

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RAB7B mRNA

NCBI chr13:45,673,396...45,699,798
Ensembl chr13:45,673,416...45,709,933

G

retinoic acid early transcript 1E

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RAET1E mRNA

NCBI chr 1:3,474,487...3,476,431

G

retinoic acid receptor, alpha

decreases expression

EXP

Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA

NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160

G

RB transcriptional corepressor 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RB1 mRNA

NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857

G

RCC1 domain containing 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RCCD1 mRNA

NCBI chr 1:143,681,124...143,690,817
Ensembl chr 1:143,681,035...143,690,362

G

retinol dehydrogenase 12

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RDH12 mRNA

NCBI chr 6:103,748,457...103,761,379
Ensembl chr 6:103,748,427...103,761,380

G

replication initiator 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of REPIN1 mRNA

NCBI chr 4:78,879,910...78,885,143
Ensembl chr 4:78,880,976...78,886,413

G

RFT1 homolog

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RFT1 mRNA

NCBI chr16:5,833,521...5,867,578
Ensembl chr16:5,833,546...5,880,165

G

regulator of cell cycle

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of RGCC mRNA

NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408

G

regulator of G-protein signaling 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of RGS1 mRNA

NCBI chr13:58,568,844...58,573,187
Ensembl chr13:58,568,844...58,573,187

G

rhomboid 5 homolog 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA

NCBI chr10:15,911,282...15,924,214
Ensembl chr10:15,911,308...15,924,214

G

rhomboid like 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RHBDL2 mRNA

NCBI chr 5:141,322,246...141,376,702
Ensembl chr 5:141,322,354...141,366,747

G

RAD9-HUS1-RAD1 interacting nuclear orphan 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RHNO1 mRNA

NCBI chr 4:163,320,141...163,325,527
Ensembl chr 4:163,320,049...163,325,790

G

ras homolog family member U

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RHOU mRNA

NCBI chr19:68,538,960...68,548,733
Ensembl chr19:68,538,960...68,548,733

G

Rho family GTPase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of RND1 mRNA

NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392

G

ring finger protein 39

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of RNF39 mRNA

NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,610,026...1,612,323

G

ribosomal protein L22 like 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RPL22L1 mRNA

NCBI chr 2:113,683,196...113,685,132
Ensembl chr 2:113,683,196...113,685,132

G

repetin

decreases expression
increases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RPTN mRNA
Sodium Dodecyl Sulfate results in increased expression of RPTN mRNA

PMID:25240866 PMID:31734321

NCBI chr 2:181,743,463...181,750,101
Ensembl chr 2:181,745,307...181,749,364

G

RWD domain containing 2B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA

NCBI chr11:40,152,139...40,166,328
Ensembl chr11:40,152,147...40,167,656

G

S100 calcium binding protein A1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of S100A1 mRNA

NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:178,291,503...178,296,346

G

S100 calcium binding protein A5

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of S100A5 mRNA

NCBI chr 2:178,392,922...178,397,128
Ensembl chr 2:178,395,121...178,397,128

G

S100 calcium binding protein A7A

increases expression
decreases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of S100A7A mRNA
Sodium Dodecyl Sulfate results in decreased expression of S100A7A mRNA

NCBI chr 2:178,448,983...178,453,424
Ensembl chr 2:178,448,983...178,453,424

G

S100 calcium binding protein A9

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of S100A9 mRNA

NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870

G

S100 calcium binding protein B

multiple interactions

ISO

Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of S100B protein

NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081

G

sterile alpha motif domain containing 4A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SAMD4A mRNA

NCBI chr15:22,616,200...22,831,872
Ensembl chr15:22,614,287...22,831,872

G

sterile alpha motif domain containing 9

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SAMD9 mRNA

NCBI chr 4:32,119,318...32,139,008
Ensembl chr 4:32,117,137...32,171,759

G

SAS-6 centriolar assembly protein

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SASS6 mRNA

NCBI chr 2:207,231,896...207,263,840
Ensembl chr 2:207,231,333...207,263,851

G

SATB homeobox 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SATB2 mRNA

NCBI chr 9:65,842,351...66,028,569
Ensembl chr 9:65,844,570...66,021,238

G

stabilizer of axonemal microtubules 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SAXO2 mRNA

NCBI chr 1:146,004,694...146,047,662
Ensembl chr 1:146,032,694...146,047,636

G

stearoyl-CoA desaturase

decreases expression
increases expression

EXP
ISO

Sodium Dodecyl Sulfate results in decreased expression of SCD1 mRNA
Sodium Dodecyl Sulfate results in increased expression of SCD mRNA

PMID:12815608 PMID:29155129

NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785

G

stromal cell-derived factor 2-like 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SDF2L1 mRNA

NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120

G

SEC14-like lipid binding 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SEC14L1 mRNA

NCBI chr10:102,818,693...102,865,841
Ensembl chr10:102,818,693...102,865,839

G

SEC22 homolog C, vesicle trafficking protein

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SEC22C mRNA

NCBI chr 8:130,223,349...130,249,079
Ensembl chr 8:130,223,349...130,247,852

G

semaphorin 3A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SEMA3A mRNA

NCBI chr 4:22,239,418...22,709,907
Ensembl chr 4:22,245,322...22,535,774

G

serine incorporator 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SERINC3 mRNA

NCBI chr 3:172,721,208...172,749,853
Ensembl chr 3:172,721,321...172,740,765

G

serpin family B member 3

decreases expression
increases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SERPINB3 protein
Sodium Dodecyl Sulfate results in increased expression of SERPINB3 mRNA

PMID:20332019 PMID:30806763

NCBI chr13:23,788,758...23,795,298
Ensembl chr13:23,788,758...23,795,298

G

serpin family E member 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SERPINE1 mRNA

NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357

G

SERTA domain containing 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SERTAD4 mRNA

NCBI chr13:106,889,019...106,899,777
Ensembl chr13:106,889,019...106,900,309

G

sphingomyelin synthase 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA

NCBI chr 2:222,567,661...222,641,804
Ensembl chr 2:222,567,664...222,590,807

G

SH3-domain binding protein 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SH3BP4 mRNA

NCBI chr 9:97,107,877...97,186,878
Ensembl chr 9:97,107,877...97,186,878

G

SH3 domain containing 21

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SH3D21 mRNA

NCBI chr 5:143,713,718...143,729,073
Ensembl chr 5:143,713,718...143,729,257

G

shroom family member 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SHROOM3 mRNA

NCBI chr14:15,383,769...15,681,158
Ensembl chr14:15,383,769...15,680,462

G

solute carrier family 20 member 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC20A1 mRNA

NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249

G

solute carrier family 22 member 3

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SLC22A3 mRNA

NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353

G

solute carrier family 22 member 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC22A4 mRNA

NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,634,098...38,679,920

G

solute carrier family 23 member 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC23A2 mRNA

NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:139,755,584...139,847,343

G

solute carrier family 25 member 24

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC25A24 mRNA

NCBI chr 2:199,449,425...199,487,287
Ensembl chr 2:199,449,345...199,487,290

G

solute carrier family 25, member 43

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SLC25A43 mRNA

NCBI chr X:120,843,181...120,877,515
Ensembl chr X:120,843,243...120,877,515

G

solute carrier family 27 member 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC27A1 mRNA

NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,313,015...18,330,045

G

solute carrier family 7 member 11

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SLC7A11 mRNA

NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695

G

solute carrier family 9 member A9

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SLC9A9 mRNA

NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891

G

SPARC related modular calcium binding 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SMOC1 mRNA

NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956

G

superoxide dismutase 1

decreases expression
increases expression

EXP
ISO

Sodium Dodecyl Sulfate results in decreased expression of SOD1 mRNA
Sodium Dodecyl Sulfate results in decreased expression of SOD1 protein
Sodium Dodecyl Sulfate results in increased expression of SOD1 mRNA

PMID:12815608 PMID:21469165

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

SRY-box transcription factor 7

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SOX7 mRNA

NCBI chr15:42,356,405...42,363,166
Ensembl chr15:42,356,289...42,363,164

G

serine peptidase inhibitor, Kazal type 6

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SPINK6 mRNA

NCBI chr18:36,648,725...36,660,902
Ensembl chr18:36,648,725...36,660,902

G

serine peptidase inhibitor, Kazal type 7

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SPINK7 mRNA

NCBI chr18:58,316,302...58,320,067
Ensembl chr18:58,316,302...58,320,067

G

small proline-rich protein 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SPRR3 mRNA

NCBI chr 2:180,723,038...180,725,695
Ensembl chr 2:180,723,061...180,725,505

G

small proline-rich protein 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SPRR4 mRNA

NCBI chr 2:180,778,079...180,778,738
Ensembl chr 2:180,778,079...180,778,738

G

sulfiredoxin 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA

NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ST6GALNAC2 mRNA

NCBI chr10:102,409,048...102,427,299
Ensembl chr10:102,409,048...102,427,137

G

signal transducer and activator of transcription 6

increases phosphorylation
multiple interactions

ISO

Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein
WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein]

NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795

G

serine/threonine kinase 10

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of STK10 mRNA

NCBI chr10:17,622,149...17,716,337
Ensembl chr10:17,622,162...17,716,332

G

sulfotransferase family 1E member 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SULT1E1 mRNA

NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,700,292...20,718,716

G

sulfotransferase family 2B member 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of SULT2B1 mRNA

NCBI chr 1:105,336,614...105,397,744
Ensembl chr 1:105,336,614...105,397,744

G

sushi domain containing 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SUSD1 mRNA

NCBI chr 5:78,952,781...79,076,121
Ensembl chr 5:78,952,781...79,070,781

G

synaptogyrin 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of SYNGR3 mRNA

NCBI chr10:14,215,088...14,219,844
Ensembl chr10:14,215,088...14,220,179

G

tachykinin, precursor 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TAC1 mRNA

NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546

G

transaldolase 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TALDO1 protein

NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535

G

transcription factor 7 like 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TCF7L2 mRNA

NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225

G

telomerase reverse transcriptase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TERT mRNA

NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111

G

testis expressed 14, intercellular bridge forming factor

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA

NCBI chr10:72,729,017...72,859,697
Ensembl chr10:72,728,985...72,853,064

G

testis expressed 261

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TEX261 mRNA

NCBI chr 4:117,813,050...117,818,408
Ensembl chr 4:117,811,176...117,819,180

G

tissue factor pathway inhibitor 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TFPI2 mRNA

NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426

G

threonine synthase-like 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of THNSL1 mRNA

NCBI chr17:88,623,054...88,630,681
Ensembl chr17:88,614,606...88,641,871

G

toll-like receptor 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TLR2 mRNA

NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194

G

transmembrane 4 L six family member 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA

NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:143,603,271...143,616,176

G

transmembrane protein 125

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TMEM125 mRNA

NCBI chr 5:137,348,545...137,349,949
Ensembl chr 5:137,345,202...137,351,952

G

transmembrane protein 177

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TMEM177 mRNA

NCBI chr13:33,576,704...33,580,129
Ensembl chr13:33,574,281...33,582,159

G

transmembrane protein 45b

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TMEM45B mRNA

NCBI chr 8:38,123,423...38,168,599
Ensembl chr 8:38,123,423...38,168,599

G

tenascin C

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TNC mRNA

NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131

G

tumor necrosis factor

increases expression
affects expression
multiple interactions
increases secretion

ISO

Sodium Dodecyl Sulfate results in increased expression of TNF mRNA
Sodium Dodecyl Sulfate affects the expression of TNF mRNA
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]
Sodium Dodecyl Sulfate results in increased secretion of TNF protein

PMID:9856837 PMID:15679580 PMID:20385217 PMID:31734321 PMID:36416909

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF alpha induced protein 3

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TNFAIP3 mRNA

PMID:20146380 PMID:31734321

NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979

G

TNF alpha induced protein 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TNFAIP6 mRNA

NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796

G

TNF superfamily member 10

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TNFSF10 mRNA

NCBI chr 2:112,136,550...112,155,903

G

Tnf receptor associated factor 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TRAF4 mRNA

NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,552,253...63,558,356

G

tripartite motif containing 6

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TRIM6 mRNA

NCBI chr 1:168,095,619...168,108,809
Ensembl chr 1:168,095,564...168,109,719

G

tRNA methyltransferase 12

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TYW2 mRNA

NCBI chr 7:92,307,319...92,308,945
Ensembl chr 7:92,307,266...92,309,346

G

tRNA splicing endonuclease subunit 54

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TSEN54 mRNA

NCBI chr10:101,540,479...101,549,022
Ensembl chr10:101,540,329...101,549,363

G

tetratricopeptide repeat domain 32

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TTC32 mRNA

NCBI chr 6:37,553,628...37,560,227
Ensembl chr 6:37,553,628...37,561,821

G

thioredoxin 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TXN mRNA

NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307

G

thioredoxin reductase 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of TXNRD1 mRNA

NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817

G

thymidine phosphorylase

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA

NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:122,316,520...122,324,003

G

ubiquitin-conjugating enzyme E2E 2

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of UBE2E2 mRNA

NCBI chr15:9,411,067...9,688,731
Ensembl chr15:9,411,539...9,712,661

G

ubiquitin-like with PHD and ring finger domains 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of UHRF1 mRNA

NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792

G

unc-51 like kinase 4

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ULK4 mRNA

NCBI chr 8:129,548,431...129,843,555
Ensembl chr 8:129,548,431...129,843,501

G

ubiquitin specific peptidase 43

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of USP43 mRNA

NCBI chr10:53,047,368...53,110,099
Ensembl chr10:53,048,158...53,110,180

G

vascular endothelial growth factor A

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of VEGFA mRNA; Sodium Dodecyl Sulfate results in increased expression of VEGFA protein

PMID:9390328 PMID:25617811 PMID:31734321

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

vascular endothelial growth factor C

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of VEGFC mRNA

NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887

G

vascular endothelial growth factor D

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of VEGFD mRNA

NCBI chr X:33,704,582...33,740,305
Ensembl chr X:33,706,055...33,740,167

G

vacuole membrane protein 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of VMP1 mRNA

NCBI chr10:71,903,223...72,002,337
Ensembl chr10:71,903,227...72,002,319

G

VPS29 retromer complex component

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of VPS29 protein

NCBI chr12:39,869,688...39,878,732
Ensembl chr12:39,869,688...39,878,848

G

vesicle trafficking 1

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein

NCBI chr 1:10,852,966...10,900,764
Ensembl chr 1:10,852,966...10,900,735

G

von Willebrand factor C and EGF domains

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of VWCE mRNA

NCBI chr 1:216,703,742...216,753,284
Ensembl chr 1:216,707,351...216,738,337

G

WD repeat domain 5B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of WDR5B mRNA

NCBI chr11:78,216,266...78,218,125
Ensembl chr11:78,190,355...78,218,501

G

YOD1 deubiquitinase

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of YOD1 mRNA

NCBI chr13:44,727,319...44,733,933

G

zinc finger and BTB domain containing 26

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZBTB26 mRNA

NCBI chr 3:41,605,097...41,617,706
Ensembl chr 3:41,603,366...41,618,704

G

zinc finger CCCH type containing 13

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ZC3H13 mRNA

NCBI chr15:57,016,686...57,081,201
Ensembl chr15:57,016,781...57,081,201

G

zinc finger CCCH type containing 8

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZC3H8 mRNA

NCBI chr 3:136,629,998...136,646,998
Ensembl chr 3:136,629,999...136,646,952

G

zinc finger CCCH-type containing, antiviral 1

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ZC3HAV1 mRNA

NCBI chr 4:67,979,055...68,029,353
Ensembl chr 4:67,979,055...68,029,353

G

ZC3HAV1 like

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZC3HAV1L mRNA

NCBI chr 4:67,957,250...67,972,540
Ensembl chr 4:67,961,862...67,968,837

G

zinc finger DHHC-type palmitoyltransferase 23

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ZDHHC23 mRNA

NCBI chr11:70,224,581...70,240,971
Ensembl chr11:70,225,045...70,240,102

G

zinc finger protein 12

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZNF12 mRNA

NCBI chr12:16,430,546...16,446,063
Ensembl chr12:16,430,581...16,450,303

G

zinc finger protein 185

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZNF185 mRNA

NCBI chr X:155,874,138...155,919,921
Ensembl chr X:155,874,127...155,917,077

G

zinc finger protein 57

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA

NCBI chr20:1,526,565...1,546,480
Ensembl chr20:1,527,961...1,535,041

G

zinc finger protein 780B

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of KRBOX5 mRNA

NCBI chr 1:92,247,941...92,297,210
Ensembl chr 1:92,223,984...92,268,523

G

zinc finger, MIZ-type containing 2

increases expression

ISO

Sodium Dodecyl Sulfate results in increased expression of ZMIZ2 mRNA

NCBI chr14:85,465,323...85,481,860
Ensembl chr14:85,465,373...85,481,860

G

zwilch kinetochore protein

decreases expression

ISO

Sodium Dodecyl Sulfate results in decreased expression of ZWILCH mRNA

NCBI chr 8:73,532,968...73,566,214
Ensembl chr 8:73,533,703...73,571,299

sodium hydrogensulfite

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

caspase 3

multiple interactions

EXP

6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

cytochrome c oxidase subunit 4i1

decreases expression

EXP

sodium bisulfite results in decreased expression of COX4 mRNA

NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624

G

mitochondrially encoded ATP synthase membrane subunit 6

decreases expression

EXP

sodium bisulfite results in decreased expression of ATP6 mRNA

NCBI chr MT:7,919...8,599
Ensembl chr MT:7,904...8,584

G

mitochondrially encoded ATP synthase membrane subunit 8

multiple interactions
decreases expression

EXP

Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of ATP8 mRNA]

NCBI chr MT:7,758...7,961
Ensembl chr MT:7,743...7,946

G

mitochondrially encoded cytochrome c oxidase I

multiple interactions
decreases expression

EXP

Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mRNA]

NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853

G

mitochondrially encoded cytochrome c oxidase II

decreases expression

EXP

sodium bisulfite results in decreased expression of COX2 mRNA

NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674

G

mitochondrially encoded cytochrome c oxidase III

multiple interactions
decreases expression

EXP

TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA]

NCBI chr MT:8,599...9,382
Ensembl chr MT:8,584...9,367

G

nitric oxide synthase 2

multiple interactions

ISO

sodium bisulfite inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]

NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880

G

nuclear respiratory factor 1

multiple interactions
decreases expression

EXP

Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA]
sodium bisulfite results in decreased expression of NRF1 mRNA; sodium bisulfite results in decreased expression of NRF1 protein

NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353

G

PPARG coactivator 1 alpha

multiple interactions
decreases expression

EXP

Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mRNA]
sodium bisulfite results in decreased expression of PPARGC1A mRNA; sodium bisulfite results in decreased expression of PPARGC1A protein

NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213

G

prostaglandin E receptor 2

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein

NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950

G

prostaglandin E receptor 4

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein

NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135

G

prostaglandin E synthase

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA

NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995

G

prostaglandin E synthase 2

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA

NCBI chr 3:36,088,246...36,095,430
Ensembl chr 3:36,088,246...36,097,694

G

prostaglandin-endoperoxide synthase 1

multiple interactions

EXP

[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]

NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990

G

prostaglandin-endoperoxide synthase 2

multiple interactions

EXP
ISO

[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]
sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 mRNA]; sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 protein]

PMID:21873648 PMID:25086357

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

transcription factor A, mitochondrial

multiple interactions
decreases expression

EXP

Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of TFAM mRNA]; TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA]
sodium bisulfite results in decreased expression of TFAM mRNA; sodium bisulfite results in decreased expression of TFAM protein

NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877

G

tumor necrosis factor

multiple interactions

ISO

sodium bisulfite inhibits the reaction [Rotenone results in increased expression of TNF mRNA]

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

multiple interactions

ISO

[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

caspase 3

multiple interactions

EXP

6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

glutamic--pyruvic transaminase

increases export

ISO

sodium sulfite results in increased export of GPT protein

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

nitric oxide synthase 1

multiple interactions

ISO

[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein

NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837

G

prostaglandin E receptor 2

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein

NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950

G

prostaglandin E receptor 4

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein

NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135

G

prostaglandin E synthase

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA

NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995

G

prostaglandin E synthase 2

multiple interactions

EXP

[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA

NCBI chr 3:36,088,246...36,095,430
Ensembl chr 3:36,088,246...36,097,694

G

prostaglandin-endoperoxide synthase 1

multiple interactions

EXP

[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]

NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990

G

prostaglandin-endoperoxide synthase 2

multiple interactions

EXP

[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

receptor interacting serine/threonine kinase 1

increases expression

ISO

sodium sulfite results in increased expression of RIPK1 protein

NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167

sodium taurocholate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

interleukin 17A

increases expression

EXP

Sodium taurocholate increases expression of Il17a mRNA and protein in the pancreas

RGD

NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331

sodium thiosulfate pentahydrate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

caspase 3

multiple interactions

EXP

sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

multiple interactions

EXP

sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP9 protein]

Ensembl chr 5:159,391,188...159,409,648

G

myeloperoxidase

multiple interactions

EXP

sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of MPO protein]

NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 1A

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB1 mRNA

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily B member 4

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB4 mRNA

NCBI chr 4:26,106,895...26,164,440

G

ATP binding cassette subfamily C member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC1 mRNA

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC2 mRNA

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ATP binding cassette subfamily C member 4

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC4 mRNA

NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375

G

ATP binding cassette subfamily G member 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG2 mRNA

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493

G

ATP binding cassette subfamily G member 5

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA

NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376

G

ATP binding cassette subfamily G member 8

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG8 mRNA

NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730

G

acetylcholinesterase

multiple interactions

EXP

[Erythrosine co-treated with Tartrazine] results in increased activity of ACHE protein

NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410

G

acyl-CoA synthetase medium-chain family member 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ACSM2A mRNA

NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453

G

adhesion G protein-coupled receptor G1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ADGRG1 mRNA

NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA

NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291

G

alcohol dehydrogenase 4 (class II), pi polypeptide

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH4 mRNA; [Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH4 mRNA

PMID:33819548 PMID:34589561

NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879

G

alcohol dehydrogenase 6 (class V)

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA

NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:229,576,636...229,607,914

G

afamin

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AFM mRNA

NCBI chr14:17,815,194...17,848,042
Ensembl chr14:17,815,194...17,848,039

G

alpha-fetoprotein

multiple interactions

EXP

[9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in increased expression of AFP protein

NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649

G

alpha-2-HS-glycoprotein

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AHSG mRNA

NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039

G

aldo-keto reductase family 1, member C1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of AKR1C1 mRNA

NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247

G

aldo-keto reductase family 1, member D1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA

NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540

G

aldo-keto reductase family 7, member A2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA

NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109

G

aldo-keto reductase family 7 member A3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA

NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153

G

albumin

multiple interactions
increases secretion
increases expression

ISO
EXP

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ALB mRNA
Tartrazine results in increased secretion of ALB protein
Tartrazine results in increased expression of ALB protein
[Tartrazine co-treated with metanil yellow co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of ALB protein; [Tartrazine co-treated with vanillin] results in increased expression of ALB protein

PMID:20678534 PMID:22317828 PMID:26862277 PMID:33819548

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

aldolase, fructose-bisphosphate B

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ALDOB mRNA

NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740

G

alkaline phosphatase, biomineralization associated

increases activity
increases expression
multiple interactions

EXP

Tartrazine results in increased activity of ALPL protein
Tartrazine results in increased expression of ALPL protein
crocin inhibits the reaction [Tartrazine results in increased activity of ALPL protein]; Nigella sativa oil inhibits the reaction [Tartrazine results in increased expression of ALPL protein]

PMID:28243541 PMID:29854586 PMID:30657462

NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167

G

adenosine monophosphate deaminase 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of AMPD3 mRNA

NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608

G

angiopoietin-like 3

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ANGPTL3 mRNA

NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444

G

apolipoprotein A1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of APOA1 mRNA

NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729

G

arginase 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ARG1 mRNA

NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713

G

arginase 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ARG2 mRNA

NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375

G

ATPase phospholipid transporting 8B1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ATP8B1 mRNA

NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027

G

ATPase, class I, type 8B, member 5

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATP8B5P mRNA

NCBI chr 5:62,302,213...62,415,843
Ensembl chr 5:62,302,275...62,415,834

G

bile acid CoA:amino acid N-acyltransferase

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of BAAT mRNA

NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181

G

BTB domain and CNC homolog 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BACH1 mRNA

NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277

G

Bcl2-like 1

multiple interactions
increases expression

ISO
EXP

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA
Aspirin inhibits the reaction [Tartrazine results in increased expression of BCL2L1 mRNA]

PMID:31032366 PMID:33819548

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907

G

calbindin 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CALB1 mRNA

NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160

G

caspase 3

multiple interactions
increases expression

EXP

crocin inhibits the reaction [Tartrazine results in increased expression of CASP3 protein]; nanocurcumin inhibits the reaction [Tartrazine results in increased expression of CASP3 mRNA]
Tartrazine results in increased expression of CASP3 mRNA; Tartrazine results in increased expression of CASP3 protein

PMID:30847814 PMID:32870427 PMID:33316931

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

multiple interactions
increases expression

EXP

[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA; nanocurcumin inhibits the reaction [Tartrazine results in increased expression of CASP9 mRNA]

PMID:32981412 PMID:33316931

Ensembl chr 5:159,391,188...159,409,648

G

catalase

decreases activity
multiple interactions
decreases expression

EXP
ISO

Tartrazine results in decreased activity of CAT protein
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CAT mRNA
Tartrazine results in decreased expression of CAT mRNA; Tartrazine results in decreased expression of CAT protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in decreased activity of CAT protein; [Erythrosine co-treated with Tartrazine] results in decreased expression of CAT protein; [Tartrazine co-treated with metanil yellow co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased activity of CAT protein; Cod Liver Oil inhibits the reaction [Tartrazine results in decreased activity of CAT protein]; crocin inhibits the reaction [Tartrazine results in decreased activity of CAT protein]; crocin inhibits the reaction [Tartrazine results in decreased expression of CAT protein]; Curcumin inhibits the reaction [Tartrazine results in decreased activity of CAT protein]; nanocurcumin inhibits the reaction [Tartrazine results in decreased expression of and results in decreased activity of CAT protein]; Nigella sativa oil inhibits the reaction [Tartrazine results in decreased expression of CAT protein]; royal jelly inhibits the reaction [Tartrazine results in decreased activity of CAT protein]; Tartrazine results in decreased expression of and results in decreased activity of CAT protein

PMID:20678534 PMID:22417523 PMID:26190785 PMID:26862277 PMID:28239801 More...

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

C-C motif chemokine ligand 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CCL2 mRNA

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

cyclin dependent kinase 2

multiple interactions
increases expression

EXP

Aspirin inhibits the reaction [Tartrazine results in increased expression of CDK2 mRNA]

NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878

G

cyclin-dependent kinase inhibitor 1B

increases expression
multiple interactions

EXP

Tartrazine results in increased expression of CDKN1B mRNA
Aspirin inhibits the reaction [Tartrazine results in increased expression of CDKN1B mRNA]

NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498

G

complement factor H-related 4

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CFHR4 mRNA

NCBI chr13:53,973,301...54,042,179
Ensembl chr13:53,973,301...54,042,179

G

cholinergic receptor nicotinic alpha 4 subunit

multiple interactions

EXP

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein

NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105

G

cholinergic receptor nicotinic beta 2 subunit

multiple interactions

EXP

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in increased expression of CHRNB2 protein

NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326

G

collagen type I alpha 1 chain

increases expression

EXP

Tartrazine results in increased expression of COL1A1 mRNA; Tartrazine results in increased expression of COL1A1 protein

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

carbamoyl-phosphate synthase 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CPS1 mRNA

NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734

G

colony stimulating factor 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CSF1 mRNA

NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468

G

cytochrome P450, family 2, subfamily b, polypeptide 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA

NCBI chr 1:90,780,468...90,859,852

G

cytochrome P450, subfamily 2, polypeptide 11

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C18 mRNA

NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853

G

cytochrome P450, family 2, subfamily c, polypeptide 79

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2C8 mRNA

G

cytochrome P450, family 2, subfamily e, polypeptide 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2E1 mRNA

NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495

G

cytochrome P450, family 3, subfamily a, polypeptide 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A4 mRNA

NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857

G

cytochrome P450, family 3, subfamily a, polypeptide 9

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA

NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154

G

cytochrome P450 family 7 subfamily A member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA; [Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA

PMID:33819548 PMID:34589561

NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202

G

cytochrome P450 family 7 subfamily B member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA

NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804

G

cytochrome P450 family 8 subfamily B member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP8B1 mRNA

NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689

G

DnaJ heat shock protein family (Hsp40) member B9

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJB9 mRNA

NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344

G

DnaJ heat shock protein family (Hsp40) member C10

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC10 mRNA

NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368

G

DnaJ heat shock protein family (Hsp40) member C18

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA

NCBI chr18:27,543,438...27,577,535
Ensembl chr18:27,543,438...27,577,535

G

DnaJ heat shock protein family (Hsp40) member C9

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA

NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304

G

delta/notch-like EGF repeat containing

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNER mRNA

NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568

G

DNA methyltransferase 1

increases expression

ISO

Tartrazine results in increased expression of DNMT1 mRNA

PMID:37447272 PMID:40077783

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

DNA methyltransferase 3 alpha

increases expression

ISO

Tartrazine results in increased expression of DNMT3A mRNA

PMID:37447272 PMID:40077783

NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970

G

DNA methyltransferase 3 beta

increases expression

ISO

Tartrazine results in increased expression of DNMT3B mRNA

PMID:37447272 PMID:40077783

NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313

G

Epstein-Barr virus induced 3

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of EBI3 mRNA

NCBI chr 9:861,441...874,731
Ensembl chr 9:870,792...874,973

G

eukaryotic translation initiation factor 2 alpha kinase 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of EIF2AK3 mRNA

NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268

G

estrogen receptor 1

increases activity
multiple interactions

ISO

Tartrazine results in increased activity of ESR1 protein
fulvestrant inhibits the reaction [Tartrazine results in increased activity of ESR1 protein]

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

ecotropic viral integration site 2B

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of EVI2B mRNA

NCBI chr10:64,970,659...64,972,277
Ensembl chr10:64,964,719...64,979,417

G

coagulation factor XIII B chain

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of F13B mRNA

NCBI chr13:53,681,639...53,707,114
Ensembl chr13:53,681,622...53,707,300

G

coagulation factor IX

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of F9 mRNA

NCBI chr X:143,388,642...143,433,143
Ensembl chr X:143,388,621...143,433,146

G

fatty acid binding protein 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FABP1 mRNA

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113

G

flavin containing dimethylaniline monoxygenase 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA

NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874

G

fibronectin 1

increases expression

EXP

Tartrazine results in increased expression of FN1 mRNA

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

follicle stimulating hormone subunit beta

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] results in increased expression of FSHB protein

NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072

G

ferritin heavy chain 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of FTH1 mRNA

NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214

G

glucose-6-phosphatase catalytic subunit 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of G6PC mRNA

NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033

G

glucosylceramidase beta 3

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GBA3 mRNA

NCBI chr14:64,787,601...64,934,043
Ensembl chr14:64,787,601...64,934,043

G

glutamate cysteine ligase, modifier subunit

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA

NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003

G

gap junction protein, beta 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GJB2 mRNA

NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877

G

glutamic-oxaloacetic transaminase 1

increases expression
increases secretion

EXP

Tartrazine results in increased expression of GOT1 protein
Tartrazine results in increased secretion of GOT1 protein

PMID:20678534 PMID:28243541 PMID:30847814

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

glutamic-oxaloacetic transaminase 2

increases activity
increases expression
multiple interactions

EXP

Tartrazine results in increased activity of GOT2 protein
Tartrazine results in increased expression of GOT2 protein
crocin inhibits the reaction [Tartrazine results in increased activity of GOT2 protein]; Nigella sativa oil inhibits the reaction [Tartrazine results in increased expression of GOT2 protein]

PMID:29854586 PMID:30657462

NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,180,431...9,206,111

G

G-protein coupled receptor 88

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPR88 mRNA

NCBI chr 2:206,876,373...206,885,034
Ensembl chr 2:206,868,585...206,884,945

G

G protein-coupled receptor, class C, group 5, member B

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GPRC5B mRNA

NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757

G

glutamic--pyruvic transaminase

increases secretion
multiple interactions
increases activity
increases expression

EXP

Tartrazine results in increased secretion of GPT protein
[Tartrazine co-treated with vanillin] results in increased activity of GPT protein; crocin inhibits the reaction [Tartrazine results in increased activity of GPT protein]; Curcumin inhibits the reaction [Tartrazine results in increased activity of GPT protein]; Nigella sativa oil inhibits the reaction [Tartrazine results in increased expression of GPT protein]

PMID:20678534 PMID:22317828 PMID:28239801 PMID:28243541 PMID:29854586 More...

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

glutathione peroxidase 1

decreases activity
multiple interactions

EXP

Tartrazine results in decreased activity of GPX1 protein
nanocurcumin inhibits the reaction [Tartrazine results in decreased expression of and results in decreased activity of GPX1 protein]; Tartrazine results in decreased expression of and results in decreased activity of GPX1 protein

PMID:22417523 PMID:33316931

NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581

G

glutamate ionotropic receptor NMDA type subunit 2A

multiple interactions

EXP

[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in increased expression of GRIN2A protein

PMID:23429044 PMID:31679476

NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378

G

glutamate ionotropic receptor NMDA type subunit 2B

multiple interactions

EXP

[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in decreased expression of GRIN2B protein

NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570

G

glutathione-disulfide reductase

decreases expression
multiple interactions
decreases activity

EXP

Tartrazine results in decreased expression of GSR protein
Nigella sativa oil inhibits the reaction [Tartrazine results in decreased expression of GSR protein]
Tartrazine results in decreased activity of GSR protein

PMID:29427609 PMID:29854586

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

glutathione S-transferase alpha 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA

NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528

G

glutathione S-transferase alpha 4

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA

NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488

G

glutathione S-transferase theta 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTT1 mRNA

NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019

G

hepatitis A virus cellular receptor 1

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA

NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268

G

histone deacetylase 2

increases expression

ISO

Tartrazine results in increased expression of HDAC2 mRNA

NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311

G

histone deacetylase 3

increases expression

ISO

Tartrazine results in increased expression of HDAC3 mRNA

NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025

G

histone deacetylase 5

increases expression

ISO

Tartrazine results in increased expression of HDAC5 mRNA

NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244

G

histone deacetylase 6

increases expression

ISO

Tartrazine results in increased expression of HDAC6 mRNA

NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370

G

histone deacetylase 8

increases expression

ISO

Tartrazine results in increased expression of HDAC8 mRNA

NCBI chr X:71,425,240...71,632,865
Ensembl chr X:71,394,928...71,632,865

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HMGCS2 mRNA

NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242

G

histamine N-methyltransferase

multiple interactions

ISO

HNMT gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with Tartrazine co-treated with ponceau 4R co-treated with Sodium Benzoate]

NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482

G

hemopexin

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of HPX mRNA

NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156

G

interferon, alpha-inducible protein 27

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI27 mRNA

NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781

G

interleukin 10

increases expression

EXP

Tartrazine results in increased expression of IL10 mRNA

NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580

G

interleukin 1 alpha

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] affects the expression of IL1A mRNA

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 beta

multiple interactions
decreases expression
affects expression
increases expression

EXP

[Tartrazine co-treated with Erythrosine] results in increased expression of IL1B mRNA
Tartrazine results in decreased expression of IL1B mRNA
Tartrazine affects the expression of IL1B mRNA
Tartrazine results in increased expression of IL1B mRNA

PMID:30096597 PMID:33565293 PMID:39619970 PMID:39866447

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 1 receptor type 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IL1R1 mRNA

NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579

G

interleukin 1 receptor-like 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IL1RL1 mRNA

NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891

G

interleukin 6

increases expression
multiple interactions
affects expression

EXP
ISO

Tartrazine results in increased expression of IL6 mRNA
[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IL6 mRNA
Tartrazine affects the expression of IL6 mRNA

PMID:30096597 PMID:34589561 PMID:39619970 PMID:39866447

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of JUN mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of JUN mRNA

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

lipocalin 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LCN2 mRNA

NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842

G

liver enriched antimicrobial peptide 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of LEAP2 mRNA

NCBI chr10:38,081,001...38,082,073
Ensembl chr10:38,081,001...38,082,073

G

luteinizing hormone subunit beta

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] results in increased expression of LHB protein

NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445

G

luteinizing hormone/choriogonadotropin receptor

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] results in increased expression of LHCGR mRNA

NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061

G

lipase C, hepatic type

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of LIPC mRNA

NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285

G

lymphocyte antigen 96

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA

NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816

G

MAF bZIP transcription factor

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAF mRNA

NCBI chr19:60,259,200...60,622,145
Ensembl chr19:60,269,541...60,621,378

G

MAF bZIP transcription factor F

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA

NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147

G

mitogen activated protein kinase kinase 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP2K2 mRNA

NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940

G

mitogen-activated protein kinase kinase 6

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA

NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721

G

mitogen-activated protein kinase kinase kinase 5

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA

NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898

G

mitogen-activated protein kinase 8

increases expression

ISO

Tartrazine results in increased expression of MAPK8 mRNA

NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427

G

MAPK activated protein kinase 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA

NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228

G

mesenteric estrogen-dependent adipogenesis

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MEDAG mRNA

NCBI chr12:10,649,526...10,670,913
Ensembl chr12:10,649,526...10,692,756

G

microsomal glutathione S-transferase 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MGST1 mRNA

NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875

G

marker of proliferation Ki-67

multiple interactions
increases expression

EXP

Aspirin inhibits the reaction [Tartrazine results in increased expression of MKI67 mRNA]

NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593

G

mixed lineage kinase domain like pseudokinase

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA

NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858

G

matrix metallopeptidase 1

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MMP1 mRNA

NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964

G

matrix metallopeptidase 10

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MMP10 mRNA

NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613

G

methylmalonyl-CoA mutase

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MMUT mRNA

NCBI chr 9:27,425,935...27,454,202
Ensembl chr 9:27,425,935...27,454,342

G

microsomal triglyceride transfer protein

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MTTP mRNA; [Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MTTP mRNA

PMID:33819548 PMID:34589561

NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650

G

mucin 1, cell surface associated

multiple interactions

EXP

[9,10-Dimethyl-1,2-benzanthracene co-treated with Tartrazine] results in increased expression of MUC1 protein

NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491

G

nitric oxide synthase 3

increases expression

EXP

Tartrazine results in increased expression of NOS3 protein

NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664

G

nuclear receptor subfamily 0, group B, member 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR0B2 mRNA

NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475

G

nuclear receptor subfamily 1, group H, member 4

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1H4 mRNA

NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389

G

nuclear receptor subfamily 1, group I, member 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I2 mRNA

NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380

G

nuclear receptor subfamily 1, group I, member 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I3 mRNA

NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370

G

ornithine transcarbamylase

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of OTC mRNA

NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555

G

phenylalanine hydroxylase

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA

NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:23,792,781...23,885,627

G

phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3C2A mRNA

NCBI chr 1:180,012,248...180,117,786
Ensembl chr 1:180,012,248...180,117,773

G

phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA

NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:174,215,527...174,581,705

G

phosphoinositide-3-kinase regulatory subunit 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3R3 mRNA

NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762

G

protein phosphatase 1, regulatory subunit 3C

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA

NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835

G

protein kinase D3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA

NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600

G

prostaglandin-endoperoxide synthase 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PTGS2 mRNA

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

pentraxin 3

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PTX3 mRNA

NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372

G

retinoic acid receptor, alpha

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RARA mRNA

NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160

G

ras related dexamethasone induced 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RASD1 mRNA

NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710

G

retinol dehydrogenase 16

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of RDH16 mRNA

NCBI chr 7:65,499,763...65,510,304

G

serpin family A member 7

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SERPINA7 mRNA

NCBI chr X:107,452,044...107,510,958
Ensembl chr X:107,452,044...107,457,681

G

serpin family E member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SERPINE1 mRNA

NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357

G

serpin family E member 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SERPINE2 mRNA

NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202

G

solute carrier family 10 member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC10A1 mRNA

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 22 member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC22A1 mRNA; [Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SLC22A1 mRNA

PMID:33819548 PMID:34589561

NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436

G

solute carrier family 22 member 7

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SLC22A7 mRNA

NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681

G

solute carrier family 2 member 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SLC2A2 mRNA

NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467

G

solute carrier family 39 member 8

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC39A8 mRNA

NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667

G

solute carrier family 5 member 3

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC5A3 mRNA

NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157

G

solute carrier family 6 member 3

multiple interactions

ISO

SLC6A3 gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with Tartrazine co-treated with ponceau 4R co-treated with Sodium Benzoate]

NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962

G

superoxide dismutase 1

decreases activity
multiple interactions
decreases expression

EXP

Tartrazine results in decreased activity of SOD1 protein
crocin inhibits the reaction [Tartrazine results in decreased expression of SOD1 protein]; Nigella sativa oil inhibits the reaction [Tartrazine results in decreased expression of SOD1 protein]
Tartrazine results in decreased expression of SOD1 mRNA; Tartrazine results in decreased expression of SOD1 protein

PMID:22417523 PMID:29854586 PMID:30847814 PMID:32870427

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

superoxide dismutase 2

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

sortilin related receptor 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SORL1 mRNA

NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:51,238,722...51,401,446

G

sterol regulatory element binding transcription factor 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SREBF1 mRNA

NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164

G

sulfotransferase family 2A member 1

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SULT2A1 mRNA; [Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SULT2A1 mRNA

PMID:33819548 PMID:34589561

NCBI chr 1:84,582,011...84,639,001

G

testis associated actin remodelling kinase 1

multiple interactions

EXP

[Tartrazine co-treated with Erythrosine] affects the expression of TESK1 mRNA

NCBI chr 5:62,487,763...62,493,492
Ensembl chr 5:62,487,763...62,493,492

G

trefoil factor 1

multiple interactions
increases expression

ISO

fulvestrant inhibits the reaction [Tartrazine results in increased expression of TFF1 mRNA]

NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956

G

tissue factor pathway inhibitor 2

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of TFPI2 mRNA

NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426

G

transforming growth factor, beta 1

increases expression

EXP

Tartrazine results in increased expression of TGFB1 mRNA; Tartrazine results in increased expression of TGFB1 protein

NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899

G

toll-like receptor 3

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR3 mRNA

NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385

G

toll-like receptor 4

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR4 mRNA

NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007

G

transmembrane protein 171

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of TMEM171 mRNA

NCBI chr 2:31,769,486...31,779,358
Ensembl chr 2:31,769,486...31,780,134

G

tenascin C

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of TNC mRNA

NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131

G

tumor necrosis factor

multiple interactions
affects expression
decreases expression

EXP

[Erythrosine co-treated with Tartrazine] results in increased expression of TNF protein; [Tartrazine co-treated with Erythrosine] affects the expression of TNF mRNA; [Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA
Tartrazine affects the expression of TNF mRNA
Tartrazine results in decreased expression of TNF mRNA

PMID:32981412 PMID:33565293 PMID:33748463 PMID:39619970 PMID:39866447

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF alpha induced protein 6

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of TNFAIP6 mRNA

NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796

G

TNF receptor superfamily member 9

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA

NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831

G

TNF superfamily member 10

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of TNFSF10 mRNA

NCBI chr 2:112,136,550...112,155,903

G

TNF superfamily member 11

multiple interactions

ISO

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFSF11 mRNA

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

tumor protein p53

decreases expression
multiple interactions
increases expression

EXP

Tartrazine results in decreased expression of TP53 mRNA
nanocurcumin inhibits the reaction [Tartrazine results in increased expression of TP53 mRNA]

PMID:31032366 PMID:33316931

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tryptophan hydroxylase 1

increases expression

ISO

Tartrazine results in increased expression of TPH1 mRNA

NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484

G

transient receptor potential cation channel, subfamily M, member 2

decreases expression
affects expression

EXP

Tartrazine results in decreased expression of TRPM2 mRNA
Tartrazine affects the expression of TRPM2 mRNA

PMID:39619970 PMID:39866447

NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802

G

vascular endothelial growth factor A

increases expression

EXP

Tartrazine results in increased expression of VEGFA protein

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

WAP four-disulfide core domain 21

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA

NCBI chr10:69,125,336...69,131,205
Ensembl chr10:69,125,320...69,131,201

G

zinc finger CCCH type containing 12A

multiple interactions

ISO

[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ZC3H12A mRNA

NCBI chr 5:142,661,193...142,670,051
Ensembl chr 5:142,661,199...142,669,985

thallium sulfate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of ALB protein

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

aquaporin 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of AQP1 mRNA

NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504

G

aquaporin 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP2 mRNA

NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319

G

aquaporin 3 (Gill blood group)

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP3 mRNA

NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685

G

aquaporin 6

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP6 mRNA

NCBI chr 7:132,611,069...132,614,004
Ensembl chr 7:132,611,065...132,614,049

G

aquaporin 7

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP7 mRNA

NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618

G

ATPase Na+/K+ transporting subunit alpha 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of ATP1A1 mRNA; [thallium sulfate results in increased abundance of Thallium] which results in increased expression of ATP1A1 mRNA

NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425

G

ATPase secretory pathway Ca2+ transporting 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of ATP2C2 mRNA

NCBI chr19:64,662,729...64,719,998
Ensembl chr19:64,662,715...64,719,996

G

calcium voltage-gated channel auxiliary subunit gamma 5

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CACNG5 mRNA

NCBI chr10:93,327,142...93,369,244
Ensembl chr10:93,327,150...93,336,667

G

calbindin 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CALB1 mRNA

NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160

G

calcium-sensing receptor

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CASR mRNA

NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167

G

clusterin

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of CLU mRNA

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

cytochrome P450, family 24, subfamily a, polypeptide 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of CYP24A1 mRNA

NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083

G

fibroblast growth factor 6

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of MT1F mRNA

NCBI chr 4:161,541,089...161,549,624
Ensembl chr 4:161,541,089...161,553,521

G

growth differentiation factor 15

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of GDF15 mRNA

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

hepatitis A virus cellular receptor 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of HAVCR1 mRNA

NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of HMGCS2 mRNA

NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242

G

heme oxygenase 1

affects expression

EXP

thallium sulfate affects the expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

potassium inwardly-rectifying channel, subfamily J, member 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNJ1 mRNA

NCBI chr 8:39,014,822...39,066,716
Ensembl chr 8:39,037,992...39,066,715

G

potassium inwardly-rectifying channel, subfamily J, member 10

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNJ10 mRNA

NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678

G

potassium calcium-activated channel subfamily M alpha 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNMA1 mRNA

NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117

G

potassium voltage-gated channel subfamily Q member 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNQ1 mRNA

NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:207,721,131...208,054,072

G

lipocalin 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of LCN2 mRNA

NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842

G

regucalcin

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of RGN mRNA

NCBI chr X:4,172,537...4,190,112
Ensembl chr X:4,172,537...4,190,251

G

sodium channel epithelial 1 subunit alpha

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SCNN1A mRNA

NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405

G

solute carrier family 12 member 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC12A1 mRNA

NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340

G

solute carrier family 12 member 3

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC12A3 mRNA

NCBI chr19:10,636,594...10,690,008
Ensembl chr19:10,636,596...10,675,050

G

solute carrier family 16 member 7

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC16A7 mRNA

NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:62,936,567...63,040,386

G

solute carrier family 20 member 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC20A2 mRNA

NCBI chr16:76,163,315...76,253,881
Ensembl chr16:76,162,922...76,253,881

G

solute carrier family 22 member 12

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SLC22A12 mRNA

NCBI chr 1:213,274,266...213,282,793
Ensembl chr 1:213,274,275...213,281,380

G

solute carrier family 26 member 7

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC26A7 mRNA

NCBI chr 5:32,681,653...32,819,110
Ensembl chr 5:32,684,288...32,818,905

G

solute carrier family 4 member 1 (Diego blood group)

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC4A1 mRNA

NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,807,013...87,823,258

G

solute carrier family 5 member 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC5A1 mRNA

NCBI chr14:81,778,495...81,843,084
Ensembl chr14:81,778,348...81,846,624

G

solute carrier family 5 member 2

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SLC5A2 mRNA

NCBI chr 1:192,277,621...192,283,742
Ensembl chr 1:192,277,621...192,283,742

G

solute carrier family 7 (cationic amino acid transporter, y+ system), member 12

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC7A12 mRNA

NCBI chr 2:88,800,954...88,868,117
Ensembl chr 2:88,800,979...88,868,103

G

solute carrier family 7 member 13

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC7A13 mRNA

NCBI chr 5:38,074,171...38,096,856
Ensembl chr 5:38,074,298...38,095,084

G

solute carrier family 8 member A1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC8A1 mRNA

NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964

G

solute carrier family 9 member A3

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC9A3 mRNA

NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002

G

solute carrier organic anion transporter family, member 1a1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLCO1A1 mRNA

NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992

G

solute carrier organic anion transporter family, member 1a6

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLCO1A6 mRNA

NCBI chr 4:176,803,025...176,848,311
Ensembl chr 4:176,803,226...176,839,032

G

secreted phosphoprotein 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SPP1 mRNA

NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820

G

transmembrane protein 252

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of TMEM252 mRNA

NCBI chr 1:231,743,396...231,748,360
Ensembl chr 1:231,743,233...231,748,358

G

transient receptor potential cation channel, subfamily V, member 5

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of TRPV5 mRNA

NCBI chr 4:71,503,085...71,531,134
Ensembl chr 4:71,503,093...71,529,384

G

uromodulin

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of UMOD mRNA

NCBI chr 1:183,247,676...183,261,665
Ensembl chr 1:183,247,674...183,261,030

G

vanin 1

multiple interactions

EXP

[thallium sulfate results in increased abundance of Thallium] which results in increased expression of VNN1 mRNA

NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629

thymol sulfate(1-)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acid phosphatase 5, tartrate resistant

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]

NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929

G

aryl hydrocarbon receptor

multiple interactions
increases activity

ISO

[4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein; Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
Thymol results in increased activity of AHR protein

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

apoptosis inducing factor, mitochondria associated 1

affects localization

ISO

Thymol affects the localization of AIFM1 protein

NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237

G

BCL2 associated X, apoptosis regulator

increases expression
multiple interactions

ISO
EXP

Thymol results in increased expression of BAX protein
Thymol inhibits the reaction [imidacloprid results in increased expression of BAX mRNA]
Thymol results in increased expression of BAX mRNA

PMID:21640085 PMID:34171690

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

decreases expression
multiple interactions

ISO
EXP

Thymol results in decreased expression of BCL2 protein
Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA]

PMID:21640085 PMID:34171690

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 1

multiple interactions

EXP

Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA]

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907

G

carbonic anhydrase 2

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]

NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064

G

caspase 3

increases activity
multiple interactions

ISO
EXP

Thymol results in increased activity of CASP3 protein
Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 mRNA]; Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 protein]

PMID:21640085 PMID:34171690

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 8

increases activity
multiple interactions

ISO
EXP

Thymol results in increased activity of CASP8 protein
Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA]

PMID:21640085 PMID:26996544

NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699

G

caspase 9

multiple interactions
increases activity

EXP
ISO

Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA]
Thymol results in increased activity of CASP9 protein

PMID:21640085 PMID:26996544

Ensembl chr 5:159,391,188...159,409,648

G

catalase

multiple interactions

ISO
EXP

Thymol inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]
Thymol inhibits the reaction [Diethylhexyl Phthalate results in increased activity of CAT protein]
Thymol inhibits the reaction [imidacloprid results in decreased activity of CAT protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]

PMID:26680107 PMID:26721194 PMID:34171690 PMID:35521929

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cathepsin K

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]

NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582

G

cytochrome P450, family 11, subfamily a, polypeptide 1

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP11A1 mRNA]

NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196

G

cytochrome P450, family 17, subfamily a, polypeptide 1

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA]

NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974

G

cytochrome P450, family 19, subfamily a, polypeptide 1

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP19A1 mRNA]

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression

ISO

Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Thymol results in increased expression of CYP1A1 mRNA

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

dendrocyte expressed seven transmembrane protein

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]

NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:72,671,477...72,707,009

G

diacylglycerol O-acyltransferase 2

multiple interactions

ISO

Thymol inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA]

NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566

G

Fas cell surface death receptor

multiple interactions

EXP

Thymol inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA]

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol promotes the reaction [Lipopolysaccharides results in decreased expression of FOS protein]

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

follicle stimulating hormone subunit beta

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in increased expression of FSHB protein]

NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072

G

GRB2-associated binding protein 2

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]

NCBI chr 1:160,841,066...161,036,940
Ensembl chr 1:160,841,066...161,036,940

G

gamma-aminobutyric acid type A receptor subunit alpha 1

multiple interactions

EXP

Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]

NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442

G

gamma-aminobutyric acid type A receptor subunit beta 2

multiple interactions

EXP

Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]

NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171

G

gamma-aminobutyric acid type A receptor subunit gamma 2

multiple interactions

EXP

Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]

NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523

G

glutathione-disulfide reductase

multiple interactions

ISO

Thymol inhibits the reaction [Dietary Fats results in decreased activity of GSR protein]

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

hydroxysteroid (17-beta) dehydrogenase 3

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of HSD17B3 mRNA]

NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283

G

heat shock protein family A (Hsp70) member 8

multiple interactions

ISO

Chloroquine inhibits the reaction [Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]]; Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

5-hydroxytryptamine receptor 3A

increases activity

ISO

Thymol results in increased activity of HTR3A protein

NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884

G

interleukin 10

multiple interactions

EXP

[Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein

NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580

G

interleukin 1 beta

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
Thymol inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]

PMID:26801986 PMID:30048646

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions

EXP

Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein]

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

luteinizing hormone subunit beta

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in increased expression of LHB protein]

NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445

G

microtubule-associated protein 1 light chain 3 alpha

increases expression
multiple interactions

ISO

Thymol results in increased expression of MAP1LC3A protein
Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein]

NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850

G

melanocyte inducing transcription factor

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]

NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790

G

matrix metallopeptidase 9

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

MYC proto-oncogene, bHLH transcription factor

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

nuclear factor of activated T-cells 1

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]

NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990

G

oxoglutarate dehydrogenase

multiple interactions

EXP

Thymol inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein]

NCBI chr14:85,363,949...85,431,405
Ensembl chr14:85,364,014...85,432,271

G

proliferating cell nuclear antigen

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of PCNA protein]

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

prostaglandin-endoperoxide synthase 2

multiple interactions

EXP

Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

EXP

Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein]

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

sequestosome 1

multiple interactions

ISO

Thymol inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]

NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]

NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462

G

sterol regulatory element binding transcription factor 1

multiple interactions

ISO

Thymol inhibits the reaction [Dietary Fats results in increased expression of SREBF1 protein]

NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164

G

steroidogenic acute regulatory protein

multiple interactions

EXP

Thymol inhibits the reaction [imidacloprid results in decreased expression of STAR mRNA]

NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447

G

transforming growth factor, beta 1

multiple interactions

ISO
EXP

Thymol inhibits the reaction [Dietary Fats results in increased expression of TGFB1 protein]
Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein]

PMID:26680107 PMID:34665902

NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899

G

tumor necrosis factor

multiple interactions

ISO
EXP

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
Thymol inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]
Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein]

PMID:26801986 PMID:30048646 PMID:34665902

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF receptor superfamily member 11A

multiple interactions

ISO

Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA]

NCBI chr13:22,442,930...22,501,257
Ensembl chr13:22,442,665...22,501,257

G

TNF superfamily member 11

multiple interactions

ISO

Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA]

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

transient receptor potential cation channel, subfamily V, member 3

increases activity

ISO

Thymol results in increased activity of TRPV3 protein

NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800

G

UDP glucuronosyltransferase family 1 member A1

increases glucuronidation

ISO

UGT1A1 protein results in increased glucuronidation of Thymol

NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase family 1 member A9

increases glucuronidation

ISO

UGT1A9 protein results in increased glucuronidation of Thymol

NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

vascular endothelial growth factor A

multiple interactions

ISO

Thymol inhibits the reaction [Dietary Fats results in increased expression of VEGFA protein]

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	20862
chemical entity	20860
atom	20860
nonmetal atom	20766
sulfur atom	18048
sulfur molecular entity	18048
sulfur oxoanion	762
(R)-4'-phospho-S-sulfopantetheine(3-)	0
(R)-4'-phosphopantetheine sulfonate(3-)	0
(R)-S-sulfopantetheine(1-)	0
(R)-pantetheine sulfonate(1-)	0
(Z)-2-aminoethene-1-SO-thioperoxolate	0
S-alkyl thiosulfate anion +	0
dioxidosulfate(.1-)	0
dioxidosulfate(2-)	0
disulfanediolate(1-)	0
disulfanediolate(2-)	0
disulfate(2-)	0
disulfite +	20
dithionate(1-)	0
dithionate(2-)	0
dithionite(1-)	0
dithionite(2-) +	14
glycosinolate +	5
hydrogensulfate +	8
hydrogensulfite +	18
hydroxidooxidosulfate(1-)	0
organic sulfamate oxoanion +	0
organosulfate oxoanion +	520
peroxydisulfate +	0
peroxysulfate(1-) +	0
peroxysulfate(2-)	0
sulfate +	563
sulfenate	0
sulfinate +	0
sulfite +	11
sulfonate +	206
tetraoxidosulfate(.1-)	0
tetrathionate ion +	0
thiosulfate(1-) +	0
thiosulfate(2-) +	3
thiosulfite(1-) +	0
thiosulfite(2-)	0
trioxidosulfate(.1-)	0
trithionate(1-)	0
trithionate(2-)	0
Path 2
Term	Annotations
CHEBI ontology	20862
subatomic particle	20860
composite particle	20860
hadron	20860
baryon	20860
nucleon	20860
atomic nucleus	20860
atom	20860
main group element atom	20781
p-block element atom	20781
chalcogen	20491
oxygen atom	20457
oxygen molecular entity	20457
oxide	12979
oxoanion	10566
chalcogen oxoanion	764
sulfur oxoanion	762
(R)-4'-phospho-S-sulfopantetheine(3-)	0
(R)-4'-phosphopantetheine sulfonate(3-)	0
(R)-S-sulfopantetheine(1-)	0
(R)-pantetheine sulfonate(1-)	0
(Z)-2-aminoethene-1-SO-thioperoxolate	0
S-alkyl thiosulfate anion +	0
dioxidosulfate(.1-)	0
dioxidosulfate(2-)	0
disulfanediolate(1-)	0
disulfanediolate(2-)	0
disulfate(2-)	0
disulfite +	20
dithionate(1-)	0
dithionate(2-)	0
dithionite(1-)	0
dithionite(2-) +	14
glycosinolate +	5
hydrogensulfate +	8
hydrogensulfite +	18
hydroxidooxidosulfate(1-)	0
organic sulfamate oxoanion +	0
organosulfate oxoanion +	520
peroxydisulfate +	0
peroxysulfate(1-) +	0
peroxysulfate(2-)	0
sulfate +	563
sulfenate	0
sulfinate +	0
sulfite +	11
sulfonate +	206
tetraoxidosulfate(.1-)	0
tetrathionate ion +	0
thiosulfate(1-) +	0
thiosulfate(2-) +	3
thiosulfite(1-) +	0
thiosulfite(2-)	0
trioxidosulfate(.1-)	0
trithionate(1-)	0
trithionate(2-)	0

paths to the root